<!DOCTYPE html>
<html lang="en-US">
  <head>
    <meta charset="UTF-8" />
    <title>Efficacy Data for Patients With FVIII Inhibitors | HEMLIBRA®</title>

    <meta
      name="description"
      content="Learn about efficacy and safety outcomes in clinical trials for HEMLIBRA® (emicizumab-kxwh) for adult and adolescent hemophilia A patients with FVIII inhibitors. See full safety and BOXED WARNING."
    />
    <meta name="template" content="flexible-page" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />

    <link rel="canonical" href="patients-with-fviii-inhibitors.html" />

    <!-- SEO -->

    <!-- Social Media -->
    <!-- og meta -->

    <meta property="og:site_name" content="hemlibra" />
    <meta property="og:type" content="website" />
    <meta property="og:locale" content="en_US" />
    <meta
      property="og:title"
      content="Efficacy Data for Patients With FVIII Inhibitors | HEMLIBRA®"
    />
    <meta
      property="og:description"
      content="Learn about efficacy and safety outcomes in clinical trials for HEMLIBRA® (emicizumab-kxwh) for adult and adolescent hemophilia A patients with FVIII inhibitors. See full safety and BOXED WARNING."
    />
    <meta
      property="og:url"
      content="https://www.hemlibra-hcp.com/trials-and-results/patients-with-fviii-inhibitors.html"
    />
    <meta
      property="og:image"
      content="https://www.hemlibra-hcp.com/content/dam/gene/hemlibra-hcp/images/logo@2x.genecoreimg.1200.png"
    />
    <meta property="og:image:type" content="image/png" />
    <meta property="og:image:width" content="374" />
    <meta property="og:image:height" content="160" />
    <meta
      property="og:image:alt"
      content="HEMLIBRA® (emicizumab-kxwh): A treatment approved for Hemophilia A patients with or without FVIII inhibitors. See Safety Information including BOXED WARNING."
    />
    <meta name="twitter:card" content="summary_large_image" />
    <!-- Favicon -->
    <link rel="icon" type="image/x-icon" />
    <link rel="shortcut icon" type="image/x-icon" />

    <link
      href="../css2.css?family=Open+Sans:ital,wght@0,400;0,700;1,400;1,700&display=swap"
      rel="stylesheet"
    />

    <script type="text/plain" class="optanon-category-C0002">
      window.NREUM||(NREUM={}),__nr_require=function(t,n,e){function r(e){if(!n[e]){var o=n[e]={exports:{}};t[e][0].call(o.exports,function(n){var o=t[e][1][n];return r(o||n)},o,o.exports)}return n[e].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<e.length;o++)r(e[o]);return r}({1:[function(t,n,e){function r(t){try{s.console&&console.log(t)}catch(n){}}var o,i=t("ee"),a=t(16),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,n,e){r(e.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,n){return t}).join(", ")))},{}],2:[function(t,n,e){function r(t,n,e,r,s){try{p?p-=1:o(s||new UncaughtException(t,n,e),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,n,e){this.message=t||"Uncaught error with no additional information",this.sourceURL=n,this.line=e}function o(t,n){var e=n?null:c.now();i("err",[t,e])}var i=t("handle"),a=t(17),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,l="nr@seenError",p=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(8),t(7),"addEventListener"in window&&t(5),c.xhrWrappable&&t(9),d=!0)}s.on("fn-start",function(t,n,e){d&&(p+=1)}),s.on("fn-err",function(t,n,e){d&&!e[l]&&(f(e,l,function(){return!0}),this.thrown=!0,o(e))}),s.on("fn-end",function(){d&&!this.thrown&&p>0&&(p-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})},{}],3:[function(t,n,e){t("loader").features.ins=!0},{}],4:[function(t,n,e){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(8),s=t(7),c="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",l="resource",p="-start",h="-end",m="fn"+p,v="fn"+h,w="bstTimer",y="pushState",g=t("loader");g.features.stn=!0,t(6);var b=NREUM.o.EV;o.on(m,function(t,n){var e=t[0];e instanceof b&&(this.bstStart=g.now())}),o.on(v,function(t,n){var e=t[0];e instanceof b&&i("bst",[e,n,this.bstStart,g.now()])}),a.on(m,function(t,n,e){this.bstStart=g.now(),this.bstType=e}),a.on(v,function(t,n){i(w,[n,this.bstStart,g.now(),this.bstType])}),s.on(m,function(){this.bstStart=g.now()}),s.on(v,function(t,n){i(w,[n,this.bstStart,g.now(),"requestAnimationFrame"])}),o.on(y+p,function(t){this.time=g.now(),this.startPath=location.pathname+location.hash}),o.on(y+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+c]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(l)]),window.performance["c"+c]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(l)]),window.performance["webkitC"+c]()},!1)),document[f]("scroll",r,{passive:!0}),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],5:[function(t,n,e){function r(t){for(var n=t;n&&!n.hasOwnProperty(u);)n=Object.getPrototypeOf(n);n&&o(n)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,n){return t[1]}var a=t("ee").get("events"),s=t(19)(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";n.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,n){var e=t[1],r=c(e,"nr@wrapped",function(){function t(){if("function"==typeof e.handleEvent)return e.handleEvent.apply(e,arguments)}var n={object:t,"function":e}[typeof e];return n?s(n,"fn-",null,n.name||"anonymous"):e});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],6:[function(t,n,e){var r=t("ee").get("history"),o=t(19)(r);n.exports=r,o.inPlace(window.history,["pushState","replaceState"],"-")},{}],7:[function(t,n,e){var r=t("ee").get("raf"),o=t(19)(r),i="equestAnimationFrame";n.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],8:[function(t,n,e){function r(t,n,e){t[0]=a(t[0],"fn-",null,e)}function o(t,n,e){this.method=e,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,e)}var i=t("ee").get("timer"),a=t(19)(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";n.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],9:[function(t,n,e){function r(t,n){d.inPlace(n,["onreadystatechange"],"fn-",s)}function o(){var t=this,n=u.context(t);t.readyState>3&&!n.resolved&&(n.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){g.push(t),h&&(x?x.then(a):v?v(a):(E=-E,O.data=E))}function a(){for(var t=0;t<g.length;t++)r([],g[t]);g.length&&(g=[])}function s(t,n){return n}function c(t,n){for(var e in t)n[e]=t[e];return n}t(5);var f=t("ee"),u=f.get("xhr"),d=t(19)(u),l=NREUM.o,p=l.XHR,h=l.MO,m=l.PR,v=l.SI,w="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],g=[];n.exports=u;var b=window.XMLHttpRequest=function(t){var n=new p(t);try{u.emit("new-xhr",[n],n),n.addEventListener(w,o,!1)}catch(e){try{u.emit("internal-error",[e])}catch(r){}}return n};if(c(p,b),b.prototype=p.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,n){r(t,n),i(n)}),u.on("open-xhr-start",r),h){var x=m&&m.resolve();if(!v&&!m){var E=1,O=document.createTextNode(E);new h(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===w||a()})},{}],10:[function(t,n,e){function r(t){var n=this.params,e=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<d;r++)t.removeEventListener(u[r],this.listener,!1);if(!n.aborted){if(e.duration=a.now()-this.startTime,4===t.readyState){n.status=t.status;var i=o(t,this.lastSize);if(i&&(e.rxSize=i),this.sameOrigin){var c=t.getResponseHeader("X-NewRelic-App-Data");c&&(n.cat=c.split(", ").pop())}}else n.status=0;e.cbTime=this.cbTime,f.emit("xhr-done",[t],t),s("xhr",[n,e,this.startTime])}}}function o(t,n){var e=t.responseType;if("json"===e&&null!==n)return n;var r="arraybuffer"===e||"blob"===e||"json"===e?t.response:t.responseText;return h(r)}function i(t,n){var e=c(n),r=t.params;r.host=e.hostname+":"+e.port,r.pathname=e.pathname,t.sameOrigin=e.sameOrigin}var a=t("loader");if(a.xhrWrappable){var s=t("handle"),c=t(11),f=t("ee"),u=["load","error","abort","timeout"],d=u.length,l=t("id"),p=t(14),h=t(13),m=window.XMLHttpRequest;a.features.xhr=!0,t(9),f.on("new-xhr",function(t){var n=this;n.totalCbs=0,n.called=0,n.cbTime=0,n.end=r,n.ended=!1,n.xhrGuids={},n.lastSize=null,p&&(p>34||p<10)||window.opera||t.addEventListener("progress",function(t){n.lastSize=t.loaded},!1)}),f.on("open-xhr-start",function(t){this.params={method:t[0]},i(this,t[1]),this.metrics={}}),f.on("open-xhr-end",function(t,n){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid)}),f.on("send-xhr-start",function(t,n){var e=this.metrics,r=t[0],o=this;if(e&&r){var i=h(r);i&&(e.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"===t.type&&(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof n.onload))&&o.end(n)}catch(e){try{f.emit("internal-error",[e])}catch(r){}}};for(var s=0;s<d;s++)n.addEventListener(u[s],this.listener,!1)}),f.on("xhr-cb-time",function(t,n,e){this.cbTime+=t,n?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof e.onload||this.end(e)}),f.on("xhr-load-added",function(t,n){var e=""+l(t)+!!n;this.xhrGuids&&!this.xhrGuids[e]&&(this.xhrGuids[e]=!0,this.totalCbs+=1)}),f.on("xhr-load-removed",function(t,n){var e=""+l(t)+!!n;this.xhrGuids&&this.xhrGuids[e]&&(delete this.xhrGuids[e],this.totalCbs-=1)}),f.on("addEventListener-end",function(t,n){n instanceof m&&"load"===t[0]&&f.emit("xhr-load-added",[t[1],t[2]],n)}),f.on("removeEventListener-end",function(t,n){n instanceof m&&"load"===t[0]&&f.emit("xhr-load-removed",[t[1],t[2]],n)}),f.on("fn-start",function(t,n,e){n instanceof m&&("onload"===e&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),f.on("fn-end",function(t,n){this.xhrCbStart&&f.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,n],n)})}},{}],11:[function(t,n,e){n.exports=function(t){var n=document.createElement("a"),e=window.location,r={};n.href=t,r.port=n.port;var o=n.href.split("://");!r.port&&o[1]&&(r.port=o[1].split("/")[0].split("@").pop().split(":")[1]),r.port&&"0"!==r.port||(r.port="https"===o[0]?"443":"80"),r.hostname=n.hostname||e.hostname,r.pathname=n.pathname,r.protocol=o[0],"/"!==r.pathname.charAt(0)&&(r.pathname="/"+r.pathname);var i=!n.protocol||":"===n.protocol||n.protocol===e.protocol,a=n.hostname===document.domain&&n.port===e.port;return r.sameOrigin=i&&(!n.hostname||a),r}},{}],12:[function(t,n,e){function r(){}function o(t,n,e){return function(){return i(t,[f.now()].concat(s(arguments)),n?null:this,e),n?void 0:this}}var i=t("handle"),a=t(16),s=t(17),c=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",p=l+"ixn-";a(d,function(t,n){u[n]=o(l+n,!0,"api")}),u.addPageAction=o(l+"addPageAction",!0),u.setCurrentRouteName=o(l+"routeName",!0),n.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,n){var e={},r=this,o="function"==typeof n;return i(p+"tracer",[f.now(),t,e],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],e),o)try{return n.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],e),t}finally{c.emit("fn-end",[f.now()],e)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,n){h[n]=o(p+n)}),newrelic.noticeError=function(t){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now()])}},{}],13:[function(t,n,e){n.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(n){return}}}},{}],14:[function(t,n,e){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),n.exports=r},{}],15:[function(t,n,e){function r(t,n){if(!o)return!1;if(t!==o)return!1;if(!n)return!0;if(!i)return!1;for(var e=i.split("."),r=n.split("."),a=0;a<r.length;a++)if(r[a]!==e[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}n.exports={agent:o,version:i,match:r}},{}],16:[function(t,n,e){function r(t,n){var e=[],r="",i=0;for(r in t)o.call(t,r)&&(e[i]=n(r,t[r]),i+=1);return e}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],17:[function(t,n,e){function r(t,n,e){n||(n=0),"undefined"==typeof e&&(e=t?t.length:0);for(var r=-1,o=e-n||0,i=Array(o<0?0:o);++r<o;)i[r]=t[n+r];return i}n.exports=r},{}],18:[function(t,n,e){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],19:[function(t,n,e){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(17),a="nr@original",s=Object.prototype.hasOwnProperty,c=!1;n.exports=function(t,n){function e(t,n,e,o){function nrWrapper(){var r,a,s,c;try{a=this,r=i(arguments),s="function"==typeof e?e(r,a):e||{}}catch(f){l([f,"",[r,a,o],s])}u(n+"start",[r,a,o],s);try{return c=t.apply(a,r)}catch(d){throw u(n+"err",[r,a,d],s),d}finally{u(n+"end",[r,a,c],s)}}return r(t)?t:(n||(n=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,n,o,i){o||(o="");var a,s,c,f="-"===o.charAt(0);for(c=0;c<n.length;c++)s=n[c],a=t[s],r(a)||(t[s]=e(a,f?s+o:o,i,s))}function u(e,r,o){if(!c||n){var i=c;c=!0;try{t.emit(e,r,o,n)}catch(a){l([a,e,r,o])}c=i}}function d(t,n){if(Object.defineProperty&&Object.keys)try{var e=Object.keys(t);return e.forEach(function(e){Object.defineProperty(n,e,{get:function(){return t[e]},set:function(n){return t[e]=n,n}})}),n}catch(r){l([r])}for(var o in t)s.call(t,o)&&(n[o]=t[o]);return n}function l(n){try{t.emit("internal-error",n)}catch(e){}}return t||(t=o),e.inPlace=f,e.flag=a,e}},{}],ee:[function(t,n,e){function r(){}function o(t){function n(t){return t&&t instanceof r?t:t?c(t,s,i):i()}function e(e,r,o,i){if(!l.aborted||i){t&&t(e,r,o);for(var a=n(o),s=m(e),c=s.length,f=0;f<c;f++)s[f].apply(a,r);var d=u[g[e]];return d&&d.push([b,e,r,a]),a}}function p(t,n){y[t]=m(t).concat(n)}function h(t,n){var e=y[t];if(e)for(var r=0;r<e.length;r++)e[r]===n&&e.splice(r,1)}function m(t){return y[t]||[]}function v(t){return d[t]=d[t]||o(e)}function w(t,n){f(t,function(t,e){n=n||"feature",g[e]=n,n in u||(u[n]=[])})}var y={},g={},b={on:p,addEventListener:p,removeEventListener:h,emit:e,get:v,listeners:m,context:n,buffer:w,abort:a,aborted:!1};return b}function i(){return new r}function a(){(u.api||u.feature)&&(l.aborted=!0,u=l.backlog={})}var s="nr@context",c=t("gos"),f=t(16),u={},d={},l=n.exports=o();l.backlog=u},{}],gos:[function(t,n,e){function r(t,n,e){if(o.call(t,n))return t[n];var r=e();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,n,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[n]=r,r}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(t,n,e){function r(t,n,e,r){o.buffer([t],r),o.emit(t,n,e)}var o=t("ee").get("handle");n.exports=r,r.ee=o},{}],id:[function(t,n,e){function r(t){var n=typeof t;return!t||"object"!==n&&"function"!==n?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");n.exports=r},{}],loader:[function(t,n,e){function r(){if(!E++){var t=x.info=NREUM.info,n=p.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&n))return u.abort();f(g,function(n,e){t[n]||(t[n]=e)}),c("mark",["onload",a()+x.offset],null,"api");var e=p.createElement("script");e.src="https://"+t.agent,n.parentNode.insertBefore(e,n)}}function o(){"complete"===p.readyState&&i()}function i(){c("mark",["domContent",a()+x.offset],null,"api")}function a(){return O.exists&&performance.now?Math.round(performance.now()):(s=Math.max((new Date).getTime(),s))-x.offset}var s=(new Date).getTime(),c=t("handle"),f=t(16),u=t("ee"),d=t(15),l=window,p=l.document,h="addEventListener",m="attachEvent",v=l.XMLHttpRequest,w=v&&v.prototype;NREUM.o={ST:setTimeout,SI:l.setImmediate,CT:clearTimeout,XHR:v,REQ:l.Request,EV:l.Event,PR:l.Promise,MO:l.MutationObserver};var y=""+location,g={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1169.min.js"},b=v&&w&&w[h]&&!/CriOS/.test(navigator.userAgent),x=n.exports={offset:s,now:a,origin:y,features:{},xhrWrappable:b,userAgent:d};t(12),p[h]?(p[h]("DOMContentLoaded",i,!1),l[h]("load",r,!1)):(p[m]("onreadystatechange",o),l[m]("onload",r)),c("mark",["firstbyte",s],null,"api");var E=0,O=t(18)},{}]},{},["loader",2,10,4,3]);
      ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"176dec39a6",applicationID:"213638407",sa:1}
    </script>

    <script>
      var dataLayer = {
        siteName: 'hemlibra',
        businessUnit: 'impact',
        indication: 'hema',
        siteAudience: 'hcp',
        topic: 'study-results',
      };
    </script>

    <script type="text/javascript" src="../gene/prod/Bootstrap.js"></script>

    <link
      href="../font-awesome/4.7.0/css/font-awesome.min.css"
      rel="stylesheet"
    />

    <link
      rel="stylesheet"
      href="../etc.clientlibs/genentech-core/clientlibs/clientlib-dependencies.min.css"
      type="text/css"
    />
    <link
      rel="stylesheet"
      href="/etc.clientlibs/hemlibra-hcp/clientlibs/clientlib-dependencies.min.css"
      type="text/css"
    />
    <link
      rel="stylesheet"
      href="../etc.clientlibs/hemlibra-hcp/clientlibs/clientlib-base.min.css"
      type="text/css"
    />
    <link
      rel="stylesheet"
      href="../etc.clientlibs/hemlibra-hcp/clientlibs/clientlib-site.min.css"
      type="text/css"
    />

    <script>
      // Need values to be formed dynamic based on the page
      var GENE = GENE || {};
      GENE.Config = GENE.Config || {};
      GENE.Config.Ensighten = [
        'hemlibra',
        'impact',
        'hema',
        'hcp',
        'study-results',
      ];
    </script>
  </head>
  <body class="page basicpage content-container" data-analytics-location="body">
    <div class="root responsivegrid">
      <div class="aem-Grid aem-Grid--12 aem-Grid--default--12">
        <div
          class="experiencefragment aem-GridColumn aem-GridColumn--default--12"
        >
          <div
            class="cmp-experiencefragment"
            data-analytics-component="experiencefragment"
            data-analytics-location="masthead"
          >
            <div class="xf-content-height">
              <div class="aem-Grid aem-Grid--12 aem-Grid--default--12">
                <div
                  class="
                    container
                    responsivegrid
                    aem-GridColumn aem-GridColumn--default--12
                  "
                >
                  <div class="cmp-container component-row">
                    <div class="cmp-container__inner content-container">
                      <div class="masthead">
                        <header
                          class="cmp-masthead component-row"
                          data-analytics-component="masthead"
                          data-sticky-option-desktop="not-sticky"
                          data-sticky-option-mobile="hide-all"
                        >
                          <div
                            class="
                              cmp-masthead__main cmp-masthead__main--nested
                              content-container
                            "
                          >
                            <!-- Utility Navigation -->
                            <nav
                              aria-label="Mobile Utility Navigation"
                              class="cmp-masthead__utility-nav-upper"
                            ></nav>

                            <div class="cmp-masthead__logo-container">
                              <a
                              href="https://uae.hcpnext.prod.opengarden.rch.cm/en/products/hemlibra.html"
                              target="_parent"
                                class="cmp-masthead__logo-url"
                                data-analytics='{\"component\":\"masthead\",\"destinationTitle\":\"HEMLIBRA® (emicizumab-kxwh): A treatment approved for Hemophilia A patients with or without FVIII inhibitors. See Safety Information including BOXED WARNING.\",\"location\":\"masthead\",\"destinationURL\":\"/index.html\",\"type\":\"internal\"}'
                              >
                                <img
                                  class="cmp-masthead__logo"
                                  alt="HEMLIBRA® (emicizumab-kxwh): A treatment approved for Hemophilia A patients with or without FVIII inhibitors. See Safety Information including BOXED WARNING."
                                  src="../content/dam/gene/hemlibra-hcp/images/logo@2x.genecoreimg.750.png"
                                />
                              </a>
                            </div>

                            <div class="cmp-masthead__menu-button-container">
                              <button
                                class="button-reset cmp-masthead__menu-button"
                              >
                                <span class="cmp-masthead__menu-button-text"
                                  >MENU</span
                                >
                                <i
                                  class="cmp-masthead__menu-button-icon fa"
                                ></i>
                              </button>
                            </div>
                            <div class="clearfix"></div>
                          </div>

                          <nav
                            class="cmp-masthead__menu"
                            aria-label="Masthead Menu"
                          >
                            <div class="navigation">
                              <nav
                                class="cmp-masthead__primary-nav"
                                aria-label="Primary Navigation"
                                data-analytics-component="navigation"
                              >
                                <ul class="cmp-masthead__primary-nav__inner">
                                  <!-- root nav items -->

                                  <li
                                    class="
                                      cmp-masthead__primary-nav__item
                                      cmp-masthead__primary-nav__item--dropdown
                                    "
                                  >
                                    <div
                                      class="cmp-masthead__primary-nav-dropdown"
                                    >
                                      <a
                                        class="
                                          cmp-masthead__primary-nav-item
                                          cmp-masthead__primary-nav-dropdown-button
                                        "
                                        href="#"
                                        data-analytics-nav-level="1"
                                        role="button"
                                        data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"About HEMLIBRA\",\"location\":\"masthead\",\"destinationURL\":\"#\",\"type\":\"state\",\"navigationLevel\":\"1\"}'
                                      >
                                        <span>About HEMLIBRA </span>
                                        <i
                                          class="
                                            cmp-masthead__primary-nav-dropdown-button-icon
                                            fa
                                          "
                                        ></i>
                                      </a>
                                    </div>
                                    <div
                                      class="
                                        cmp-masthead__primary-nav-dropdown-content
                                      "
                                    >
                                      <ul
                                        class="
                                          cmp-masthead__primary-nav-dropdown-list
                                          cmp-masthead__primary-nav-dropdown-list--level2
                                        "
                                      >
                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                          "
                                        >
                                          <!-- drop down items -->
                                          <a
                                            data-analytics-nav-level="2"
                                            href="https://uae.hcpnext.prod.opengarden.rch.cm/en/products/hemlibra/about-hemlibra/why-hemlibra.html"
                                            target="_parent"
                                            class="
                                              cmp-masthead__primary-nav-dropdown-item
                                              cmp-masthead__primary-nav-dropdown-item--level2
                                            "
                                            data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Why HEMLIBRA?\",\"location\":\"masthead\",\"destinationURL\":\"/about-hemlibra/why-hemlibra.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                            >Why HEMLIBRA?</a
                                          >
                                          <!-- 3rd level link -->
                                        </li>

                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                          "
                                        >
                                          <!-- drop down items -->
                                          <a
                                            data-analytics-nav-level="2"
                                            href="https://uae.hcpnext.prod.opengarden.rch.cm/en/products/hemlibra/about-hemlibra/hear-from-a-peer.html"
                                            target="_parent"
                                            class="
                                              cmp-masthead__primary-nav-dropdown-item
                                              cmp-masthead__primary-nav-dropdown-item--level2
                                            "
                                            data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Hear From a Peer\",\"location\":\"masthead\",\"destinationURL\":\"/about-hemlibra/hear-from-a-peer.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                            >Hear From a Peer</a
                                          >
                                          <!-- 3rd level link -->
                                        </li>

                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                          "
                                        >
                                          <!-- drop down items -->
                                          <a
                                            data-analytics-nav-level="2"
                                            href="https://uae.hcpnext.prod.opengarden.rch.cm/en/products/hemlibra/about-hemlibra/hemlibra-half-life.html"
                                            target="_parent"
                                            class="
                                              cmp-masthead__primary-nav-dropdown-item
                                              cmp-masthead__primary-nav-dropdown-item--level2
                                            "
                                            data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"HEMLIBRA Half-Life &amp; Pharmacokinetics\",\"location\":\"masthead\",\"destinationURL\":\"/about-hemlibra/hemlibra-half-life.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                            >HEMLIBRA Half-Life &amp;
                                            Pharmacokinetics</a
                                          >
                                          <!-- 3rd level link -->
                                        </li>

                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                          "
                                        >
                                          <!-- drop down items -->
                                          <a
                                            data-analytics-nav-level="2"
                                            href="https://uae.hcpnext.prod.opengarden.rch.cm/en/products/hemlibra/about-hemlibra/mechanism-of-action.html"
                                            target="_parent"
                                            class="
                                              cmp-masthead__primary-nav-dropdown-item
                                              cmp-masthead__primary-nav-dropdown-item--level2
                                            "
                                            data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Mechanism of Action\",\"location\":\"masthead\",\"destinationURL\":\"/about-hemlibra/mechanism-of-action.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                            >Mechanism of Action</a
                                          >
                                          <!-- 3rd level link -->
                                        </li>
                                      </ul>
                                    </div>
                                  </li>

                                  <li
                                    class="
                                      cmp-masthead__primary-nav__item
                                      cmp-masthead-primary-nav__item--selected
                                      cmp-masthead__primary-nav__item--dropdown
                                    "
                                  >
                                    <div
                                      class="cmp-masthead__primary-nav-dropdown"
                                    >
                                      <a
                                        class="
                                          cmp-masthead__primary-nav-item
                                          cmp-masthead__primary-nav-dropdown-button
                                        "
                                        href="#"
                                        data-analytics-nav-level="1"
                                        role="button"
                                        data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Trials &amp; Results\",\"location\":\"masthead\",\"destinationURL\":\"#\",\"type\":\"state\",\"navigationLevel\":\"1\"}'
                                      >
                                        <span>Trials &amp; Results</span>
                                        <i
                                          class="
                                            cmp-masthead__primary-nav-dropdown-button-icon
                                            fa
                                          "
                                        ></i>
                                      </a>
                                    </div>
                                    <div
                                      class="
                                        cmp-masthead__primary-nav-dropdown-content
                                      "
                                    >
                                      <ul
                                        class="
                                          cmp-masthead__primary-nav-dropdown-list
                                          cmp-masthead__primary-nav-dropdown-list--level2
                                        "
                                      >
                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                          "
                                        >
                                          <!-- drop down items -->
                                          <a
                                            data-analytics-nav-level="2"
                                            href="hemlibra-clinical-trials.html"
                                            class="
                                              cmp-masthead__primary-nav-dropdown-item
                                              cmp-masthead__primary-nav-dropdown-item--level2
                                            "
                                            data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"HEMLIBRA Clinical Trials\",\"location\":\"masthead\",\"destinationURL\":\"/trials-and-results/hemlibra-clinical-trials.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                            >HEMLIBRA Clinical Trials</a
                                          >
                                          <!-- 3rd level link -->
                                        </li>

                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                          "
                                        >
                                          <!-- drop down items -->
                                          <a
                                            data-analytics-nav-level="2"
                                            href="patients-without-fviii-inhibitors.html"
                                            class="
                                              cmp-masthead__primary-nav-dropdown-item
                                              cmp-masthead__primary-nav-dropdown-item--level2
                                            "
                                            data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Patients Without FVIII Inhibitors\",\"location\":\"masthead\",\"destinationURL\":\"/trials-and-results/patients-without-fviii-inhibitors.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                            >Patients Without FVIII
                                            Inhibitors</a
                                          >
                                          <!-- 3rd level link -->
                                        </li>

                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                            cmp-masthead__primary-nav-dropdown-items--selected
                                          "
                                        >
                                          <!-- drop down items -->
                                          <a
                                            data-analytics-nav-level="2"
                                            href="patients-with-fviii-inhibitors.html"
                                            class="
                                              cmp-masthead__primary-nav-dropdown-item
                                              cmp-masthead__primary-nav-dropdown-item--level2
                                            "
                                            data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Patients With FVIII Inhibitors\",\"location\":\"masthead\",\"destinationURL\":\"/trials-and-results/patients-with-fviii-inhibitors.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                            >Patients With FVIII Inhibitors</a
                                          >
                                          <!-- 3rd level link -->
                                        </li>

                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                          "
                                        >
                                          <!-- drop down items -->
                                          <a
                                            data-analytics-nav-level="2"
                                            href="pediatric-patients.html"
                                            class="
                                              cmp-masthead__primary-nav-dropdown-item
                                              cmp-masthead__primary-nav-dropdown-item--level2
                                            "
                                            data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Pediatric Patients\",\"location\":\"masthead\",\"destinationURL\":\"/trials-and-results/pediatric-patients.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                            >Pediatric Patients</a
                                          >
                                          <!-- 3rd level link -->
                                        </li>
                                      </ul>
                                    </div>
                                  </li>

                                  <li
                                    class="
                                      cmp-masthead__primary-nav__item
                                      cmp-masthead__primary-nav__item--dropdown
                                    "
                                  >
                                    <div
                                      class="cmp-masthead__primary-nav-dropdown"
                                    >
                                      <a
                                        class="
                                          cmp-masthead__primary-nav-item
                                          cmp-masthead__primary-nav-dropdown-button
                                        "
                                        href="#"
                                        data-analytics-nav-level="1"
                                        role="button"
                                        data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Dosing &amp; Administration\",\"location\":\"masthead\",\"destinationURL\":\"#\",\"type\":\"state\",\"navigationLevel\":\"1\"}'
                                      >
                                        <span>Dosing &amp; Administration</span>
                                        <i
                                          class="
                                            cmp-masthead__primary-nav-dropdown-button-icon
                                            fa
                                          "
                                        ></i>
                                      </a>
                                    </div>
                                    <div
                                      class="
                                        cmp-masthead__primary-nav-dropdown-content
                                      "
                                    >
                                      <ul
                                        class="
                                          cmp-masthead__primary-nav-dropdown-list
                                          cmp-masthead__primary-nav-dropdown-list--level2
                                        "
                                      >
                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                          "
                                        >
                                          <!-- drop down items -->
                                          <a
                                            data-analytics-nav-level="2"
                                            href="https://uae.hcpnext.prod.opengarden.rch.cm/en/products/hemlibra/dosing-administration/dosing.html"
                                            target="_parent"
                                            class="
                                              cmp-masthead__primary-nav-dropdown-item
                                              cmp-masthead__primary-nav-dropdown-item--level2
                                            "
                                            data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"HEMLIBRA Dosing Options\",\"location\":\"masthead\",\"destinationURL\":\"/dosing-administration/dosing.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                            >HEMLIBRA Dosing Options</a
                                          >
                                          <!-- 3rd level link -->
                                        </li>

                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                          "
                                        >
                                          <!-- drop down items -->
                                          <a
                                            data-analytics-nav-level="2"
                                            href="https://uae.hcpnext.prod.opengarden.rch.cm/en/products/hemlibra/dosing-administration/dosing-calculator.html"
                                            target="_parent"
                                            class="
                                              cmp-masthead__primary-nav-dropdown-item
                                              cmp-masthead__primary-nav-dropdown-item--level2
                                            "
                                            data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Dosing Calculator\",\"location\":\"masthead\",\"destinationURL\":\"/dosing-administration/dosing-calculator.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                            >Dosing Calculator</a
                                          >
                                          <!-- 3rd level link -->
                                        </li>

                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                          "
                                        >
                                          <!-- drop down items -->
                                          <a
                                            data-analytics-nav-level="2"
                                            href="https://uae.hcpnext.prod.opengarden.rch.cm/en/products/hemlibra/dosing-administration/administration-preparation.html"
                                            target="_parent"
                                            class="
                                              cmp-masthead__primary-nav-dropdown-item
                                              cmp-masthead__primary-nav-dropdown-item--level2
                                            "
                                            data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Preparation &amp; Administration\",\"location\":\"masthead\",\"destinationURL\":\"/dosing-administration/administration-preparation.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                            >Preparation &amp; Administration</a
                                          >
                                          <!-- 3rd level link -->
                                        </li>
                                      </ul>
                                    </div>
                                  </li>

                                  <li
                                    class="
                                      cmp-masthead__primary-nav__item
                                      cmp-masthead__primary-nav__item--dropdown
                                    "
                                  >
                                    <div
                                      class="cmp-masthead__primary-nav-dropdown"
                                    >
                                      <a
                                        class="
                                          cmp-masthead__primary-nav-item
                                          cmp-masthead__primary-nav-dropdown-button
                                        "
                                        href="#"
                                        data-analytics-nav-level="1"
                                        role="button"
                                        data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Safety &amp; Patient Management\",\"location\":\"masthead\",\"destinationURL\":\"#\",\"type\":\"state\",\"navigationLevel\":\"1\"}'
                                      >
                                        <span
                                          >Safety &amp; Patient Management</span
                                        >
                                        <i
                                          class="
                                            cmp-masthead__primary-nav-dropdown-button-icon
                                            fa
                                          "
                                        ></i>
                                      </a>
                                    </div>
                                    <div
                                      class="
                                        cmp-masthead__primary-nav-dropdown-content
                                      "
                                    >
                                      <ul
                                        class="
                                          cmp-masthead__primary-nav-dropdown-list
                                          cmp-masthead__primary-nav-dropdown-list--level2
                                        "
                                      >
                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                          "
                                        >
                                          <!-- drop down items -->
                                          <a
                                            data-analytics-nav-level="2"
                                            href="https://uae.hcpnext.prod.opengarden.rch.cm/en/products/hemlibra/safety-and-patient-management/demonstrated-safety-profile.html"
                                            target="_parent"
                                            class="
                                              cmp-masthead__primary-nav-dropdown-item
                                              cmp-masthead__primary-nav-dropdown-item--level2
                                            "
                                            data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Demonstrated Safety Profile\",\"location\":\"masthead\",\"destinationURL\":\"/safety-and-patient-management/demonstrated-safety-profile.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                            >Demonstrated Safety Profile</a
                                          >
                                          <!-- 3rd level link -->
                                        </li>

                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                          "
                                        >
                                          <!-- drop down items -->
                                          <a
                                            data-analytics-nav-level="2"
                                            href="https://uae.hcpnext.prod.opengarden.rch.cm/en/products/hemlibra/safety-and-patient-management/laboratory-monitoring.html"
                                            target="_parent"
                                            class="
                                              cmp-masthead__primary-nav-dropdown-item
                                              cmp-masthead__primary-nav-dropdown-item--level2
                                            "
                                            data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Laboratory Monitoring\",\"location\":\"masthead\",\"destinationURL\":\"/safety-and-patient-management/laboratory-monitoring.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                            >Laboratory Monitoring
                                          </a>
                                          <!-- 3rd level link -->
                                        </li>

                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                          "
                                        >
                                          <!-- drop down items -->
                                          <a
                                            data-analytics-nav-level="2"
                                            href="https://uae.hcpnext.prod.opengarden.rch.cm/en/products/hemlibra/safety-and-patient-management/treating-breakthrough-bleeds.html"
                                            target="_parent"
                                            class="
                                              cmp-masthead__primary-nav-dropdown-item
                                              cmp-masthead__primary-nav-dropdown-item--level2
                                            "
                                            data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Treating Breakthrough Bleeds\",\"location\":\"masthead\",\"destinationURL\":\"/safety-and-patient-management/treating-breakthrough-bleeds.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                            >Treating Breakthrough Bleeds</a
                                          >
                                          <!-- 3rd level link -->
                                        </li>

                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                          "
                                        >
                                          <!-- drop down items -->
                                          <a
                                            data-analytics-nav-level="2"
                                            href="https://uae.hcpnext.prod.opengarden.rch.cm/en/products/hemlibra/safety-and-patient-management/retrospective-surgery-experience.html"
                                            target="_parent"
                                            class="
                                              cmp-masthead__primary-nav-dropdown-item
                                              cmp-masthead__primary-nav-dropdown-item--level2
                                            "
                                            data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Retrospective Surgery Experience\",\"location\":\"masthead\",\"destinationURL\":\"/safety-and-patient-management/retrospective-surgery-experience.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                            >Retrospective Surgery Experience</a
                                          >
                                          <!-- 3rd level link -->
                                        </li>
                                      </ul>
                                    </div>
                                  </li>

                                  <li
                                    class="
                                      cmp-masthead__primary-nav__item
                                      cmp-masthead__primary-nav__item--dropdown
                                    "
                                  >
                                    <div
                                      class="cmp-masthead__primary-nav-dropdown"
                                    >
                                      <a
                                        data-analytics-nav-level="2"
                                        href="https://uae.hcpnext.prod.opengarden.rch.cm/en/products/hemlibra/frequently-asked-questions.html"
                                        target="_parent"
                                        class="
                                          cmp-masthead__primary-nav-dropdown-item
                                          cmp-masthead__primary-nav-dropdown-item--level2
                                        "
                                        data-analytics='{\"component\":\"navigation\",\"destinationTitle\":\"Frequently Asked Questions\",\"location\":\"masthead\",\"destinationURL\":\"/https://uae.hcpnext.prod.opengarden.rch.cm/en/products/hemlibra/frequently-asked-questions.html\",\"type\":\"internal\",\"navigationLevel\":\"2\"}'
                                        >Frequently Asked Questions</a
                                      >
                                    </div>
                                    <div
                                      class="
                                        cmp-masthead__primary-nav-dropdown-content
                                      "
                                    >
                                      <ul
                                        class="
                                          cmp-masthead__primary-nav-dropdown-list
                                          cmp-masthead__primary-nav-dropdown-list--level2
                                        "
                                      >
                                        <li
                                          class="
                                            cmp-masthead__primary-nav-dropdown-items
                                          "
                                        >
                                          <!-- drop down items -->

                                          <!-- 3rd level link -->
                                        </li>
                                      </ul>
                                    </div>
                                  </li>

                                  <!-- multi-field nav items  -->
                                </ul>
                              </nav>
                            </div>

                            <!-- /* Mobile Utility Nav */-->
                            <div class="cmp-masthead__utility-nav-mobile">
                              <a
                                class="cmp-masthead__utility-nav-mobile-item"
                                href="../contact-rep.html"
                                target="_self"
                                data-analytics='{\"component\":\"masthead\",\"destinationTitle\":\" \",\"location\":\"masthead\",\"destinationURL\":\"/contact-rep.html\",\"type\":\"internal\"}'
                              >
                                <span
                                  class="
                                    cmp-masthead__utility-nav-mobile-item-text
                                  "
                                >
                                </span>
                                <i
                                  class="
                                    cmp-masthead__utility-nav-mobile-item-icon
                                    fa
                                    no-icon
                                  "
                                ></i>
                              </a>

                              <a
                                class="cmp-masthead__utility-nav-mobile-item"
                                href="https://uae.hcpnext.prod.opengarden.rch.cm/en/products/hemlibra/dosing-administration/dosing-calculator.html"
                                target="_parent"
                                target="_self"
                                data-analytics='{\"component\":\"masthead\",\"destinationTitle\":\"Dosing Calculator\",\"location\":\"masthead\",\"destinationURL\":\"/dosing-administration/dosing-calculator.html\",\"type\":\"internal\"}'
                              >
                                <span
                                  class="
                                    cmp-masthead__utility-nav-mobile-item-text
                                  "
                                  >Dosing Calculator</span
                                >
                                <i
                                  class="
                                    cmp-masthead__utility-nav-mobile-item-icon
                                    fa
                                    no-icon
                                  "
                                ></i>
                              </a>

                              <a
                                class="cmp-masthead__utility-nav-mobile-item"
                                href="../download/pdf/hemlibra_prescribing.pdf"
                                target="_blank"
                                data-analytics='{\"component\":\"masthead\",\"destinationTitle\":\"Prescribing Information\",\"location\":\"masthead\",\"destinationURL\":\"https://www.gene.com/download/pdf/hemlibra_prescribing.pdf\",\"type\":\"external\"}'
                              >
                                <span
                                  class="
                                    cmp-masthead__utility-nav-mobile-item-text
                                  "
                                  >Prescribing Information</span
                                >
                                <i
                                  class="
                                    cmp-masthead__utility-nav-mobile-item-icon
                                    fa
                                    no-icon
                                  "
                                ></i>
                              </a>

                              <a
                                class="cmp-masthead__utility-nav-mobile-item"
                                href="../safety.html"
                                target="_self"
                                data-analytics='{\"component\":\"masthead\",\"destinationTitle\":\"Safety\",\"location\":\"masthead\",\"destinationURL\":\"/safety.html\",\"type\":\"internal\"}'
                              >
                                <span
                                  class="
                                    cmp-masthead__utility-nav-mobile-item-text
                                  "
                                  >Safety</span
                                >
                                <i
                                  class="
                                    cmp-masthead__utility-nav-mobile-item-icon
                                    fa
                                    no-icon
                                  "
                                ></i>
                              </a>
                            </div>

                            <a
                              class="
                                cmp-masthead__feature-link
                                cmp-masthead__feature-link--mobile
                                no-external-icon
                              "
                              href="../patient.html"
                              target="_blank"
                              data-analytics='{\"component\":\"masthead\",\"destinationTitle\":\"For Patients &amp; Caregivers\",\"location\":\"masthead\",\"destinationURL\":\"https://www.hemlibra.com/\",\"type\":\"external\"}'
                            >
                              <span class="cmp-masthead__feature-link-text"
                                >For Patients &amp; Caregivers</span
                              >
                              <i
                                class="
                                  cmp-masthead__feature-link-icon
                                  fa fa-external-link
                                "
                              ></i>
                            </a>
                          </nav>
                        </header>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div
          class="
            container
            responsivegrid
            aem-GridColumn aem-GridColumn--default--12
          "
        >
          <div
            id="page-content-top"
            class="cmp-container component-row"
            data-analytics-location="body"
          >
            <div class="cmp-container__inner content-container">
              <div class="hero">
                <section
                  class="cmp-hero component-row comp-margin-bottom"
                  data-analytics-component="hero"
                >
                  <div
                    class="positionable-background cmp-hero__image Left"
                    role="img"
                    srcset='["/content/dam/gene/hemlibra-hcp/images/hemlibra-hcp-interior-header-image@2x.png",
                           "/content/dam/gene/hemlibra-hcp/images/hemlibra-hcp-interior-header-image@2x.png",
                           ""]'
                  >
                    <div class="cmp-hero__inner cmp-hero__inner--content-top">
                      <div
                        class="
                          cmp-hero__content cmp-hero__content--desktop
                          None
                        "
                      >
                        <div>
                          <div class="text">
                            <div
                              class="cmp-text"
                              data-analytics-component="text"
                              data-table-stacked-on-mobile="false"
                              data-table-lock-first-column="false"
                            >
                              <h1>
                                Efficacy for Adults and Adolescents With FVIII
                                Inhibitors
                              </h1>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>

                  <div
                    class="cmp-hero__content cmp-hero__content--mobile"
                    style="border: 1px solid"
                  >
                    <div
                      class="cmp-text"
                      data-analytics-component="text"
                      data-table-stacked-on-mobile="false"
                      data-table-lock-first-column="false"
                    >
                      <h1>
                        Efficacy for Adults and Adolescents With FVIII
                        Inhibitors
                      </h1>
                    </div>
                  </div>
                </section>
              </div>
              <div class="container responsivegrid site-max-width">
                <div class="cmp-container component-row">
                  <div class="cmp-container__inner content-container">
                    <div
                      class="
                        content-block
                        cmp-content-block-_mobile-2-col cmp-content-block-_wide
                        cmp-content-block--align-middle
                        cmp-content-block--no-button
                      "
                    >
                      <section
                        class="cmp-content-block"
                        target="_self"
                        data-analytics-component="contentblock"
                      >
                        <div class="cmp-content-block__inner">
                          <div class="cmp-content-block__icon-container">
                            <img
                              class="cmp-content-block__icon"
                              alt=""
                              src="../etc.clientlibs/genentech-core/clientlibs/clientlib-site/resources/images/optimized-img-placeholder.png"
                              sizes="(max-width: 600px) 480px, 800px"
                              srcset="
                                /content/dam/gene/hemlibra-hcp/images/haven-1-icon-desktop@2x.png 800w
                              "
                            />
                          </div>

                          <div class="cmp-content-block__copy">
                            <p>
                              <b
                                >Adults and adolescents with inhibitors<sup
                                  ><span class="reference">8</span></sup
                                ></b
                              >
                            </p>
                            <ul>
                              <li>1.5 mg/kg QW</li>
                            </ul>
                          </div>
                          <div
                            class="cmp-content-block__button-container"
                          ></div>
                        </div>
                      </section>
                    </div>
                    <div class="text">
                      <div
                        class="cmp-text"
                        data-analytics-component="text"
                        data-table-stacked-on-mobile="false"
                        data-table-lock-first-column="false"
                      >
                        <h3>Aim for zero treated bleeds</h3>
                        <h4>
                          The majority of hemophilia A patients receiving
                          HEMLIBRA had zero bleeds* requiring treatment.<sup
                            ><span class="reference">5</span></sup
                          >
                        </h4>
                      </div>
                    </div>
                    <div
                      class="
                        container
                        responsivegrid
                        callout callout--basic-squared
                      "
                    >
                      <div class="cmp-container component-row">
                        <div class="cmp-container__inner content-container">
                          <div class="text">
                            <div
                              class="cmp-text"
                              data-analytics-component="text"
                              data-table-stacked-on-mobile="false"
                              data-table-lock-first-column="false"
                            >
                              <p>
                                <span class="h3"
                                  >Percentage of patients who had zero treated
                                  bleeds with HEMLIBRA</span
                                ><br />
                                (primary endpoint)
                              </p>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                    <div class="responsiveimage">
                      <div
                        data-analytics-component="responsiveimage"
                        data-linktype="linkPath"
                        class="cmp-responsiveimg comp-margin-bottom"
                      >
                        <div
                          class="cmp-responsiveimg__inner"
                          style="max-width: 310px"
                        >
                          <img
                            class="cmp-responsiveimg__image"
                            alt="Zero treated bleeds data for HAVEN 1."
                            src="../etc.clientlibs/genentech-core/clientlibs/clientlib-site/resources/images/optimized-img-placeholder.png"
                            sizes="(max-width: 600px) 480px, 800px"
                            srcset="
                              /content/dam/gene/hemlibra-hcp/images/haven-1-randomized-comparison-chart-desktop@2x.png 800w
                            "
                          />
                        </div>
                      </div>
                    </div>
                    <div class="text">
                      <div
                        class="cmp-text"
                        data-analytics-component="text"
                        data-table-stacked-on-mobile="false"
                        data-table-lock-first-column="false"
                      >
                        <p>
                          <span class="footnote-text"
                            ><sup>*</sup>Defined as bleeds treated with
                            bypassing agents based on an adaptation of standard
                            criteria defined by the International Society on
                            Thrombosis and Haemostasis (ISTH).<sup
                              ><span class="reference">15</span></sup
                            ></span
                          >
                        </p>
                      </div>
                    </div>
                    <div
                      class="
                        container
                        responsivegrid
                        callout callout--basic-rounded
                      "
                    >
                      <div class="cmp-container component-row">
                        <div class="cmp-container__inner content-container">
                          <div class="text">
                            <div
                              class="cmp-text"
                              data-analytics-component="text"
                              data-table-stacked-on-mobile="false"
                              data-table-lock-first-column="false"
                            >
                              <p>
                                <span class="h3"
                                  >“In the first 5 months since I started using
                                  HEMLIBRA, I have not treated a single bleed.
                                  HEMLIBRA is working for me.”</span
                                ><br />
                                <span class="quote-attribution"
                                  >A 26-year-old with hemophilia A with FVIII
                                  inhibitors, California</span
                                >
                              </p>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                    <div class="text">
                      <div
                        class="cmp-text"
                        data-analytics-component="text"
                        data-table-stacked-on-mobile="false"
                        data-table-lock-first-column="false"
                      >
                        <h3>
                          Long-term descriptive analysis in adults and
                          adolescents with FVIII inhibitors<sup
                            ><span class="reference">1,14</span></sup
                          >
                        </h3>
                      </div>
                    </div>
                    <div
                      class="
                        container
                        responsivegrid
                        callout callout--basic-squared
                      "
                    >
                      <div
                        class="
                          cmp-container
                          component-row
                          cmp-container--has-background
                        "
                        style="background-color: #e9eaeb"
                      >
                        <div class="cmp-container__inner content-container">
                          <div class="text">
                            <div
                              class="cmp-text"
                              data-analytics-component="text"
                              data-table-stacked-on-mobile="false"
                              data-table-lock-first-column="false"
                            >
                              <p>
                                <span class="h3"
                                  >Percent of patients with zero treated bleeds
                                  measured in 24-week intervals over 96
                                  weeks</span
                                >
                              </p>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                    <div class="responsiveimage">
                      <div
                        data-analytics-component="responsiveimage"
                        data-linktype="linkPath"
                        class="cmp-responsiveimg comp-margin-bottom"
                      >
                        <div
                          class="cmp-responsiveimg__inner"
                          style="max-width: 582px"
                        >
                          <img
                            class="cmp-responsiveimg__image"
                            alt="Long-term descriptive analysis of zero treated bleeds in HAVEN 1."
                            src="../etc.clientlibs/genentech-core/clientlibs/clientlib-site/resources/images/optimized-img-placeholder.png"
                            sizes="(max-width: 600px) 480px, 800px"
                            srcset="
                              /content/dam/gene/hemlibra-hcp/images/hemlibra-haven-1-long-term-bleed-data-chart-desktop.jpg 800w
                            "
                          />
                        </div>
                      </div>
                    </div>
                    <div class="text">
                      <div
                        class="cmp-text"
                        data-analytics-component="text"
                        data-table-stacked-on-mobile="false"
                        data-table-lock-first-column="false"
                      >
                        <p>
                          <span class="footnote-text"
                            >n=number of patients who contributed data for
                            analyses at each time interval.</span
                          >
                        </p>
                        <h4>
                          Benefit conclusions about the bleed rates over time
                          with HEMLIBRA cannot be drawn
                        </h4>
                        <ul>
                          <li>The 95% CIs overlap in each group</li>
                          <li>
                            The sample size for Weeks 73–96 is also smaller,
                            which limits interpretation of a definitive
                            improvement
                          </li>
                        </ul>
                        <h3>
                          Intra-individual comparison of treated bleeding events
                          with HEMLIBRA vs previous BPAs<sup
                            ><span class="reference">15</span></sup
                          >
                        </h3>
                        <div> </div>
                      </div>
                    </div>
                    <div
                      class="
                        container
                        responsivegrid
                        callout callout--basic-squared
                      "
                    >
                      <div class="cmp-container component-row">
                        <div class="cmp-container__inner content-container">
                          <div class="text">
                            <div
                              class="cmp-text"
                              data-analytics-component="text"
                              data-table-stacked-on-mobile="false"
                              data-table-lock-first-column="false"
                            >
                              <p>
                                <span
                                  class="callout__flag callout__flag--blue-dark"
                                  >INTRA-individual<br />
                                  Comparison</span
                                >
                              </p>
                              <p>
                                <span class="h3"
                                  >HAVEN 1<sup>†</sup>: Individual patient
                                  ABR</span
                                >
                              </p>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                    <div class="responsiveimage">
                      <div
                        data-analytics-component="responsiveimage"
                        data-linktype="linkPath"
                        class="cmp-responsiveimg comp-margin-bottom"
                      >
                        <div class="cmp-responsiveimg__inner" style="280">
                          <img
                            class="cmp-responsiveimg__image"
                            alt="HAVEN 1: Individual patient ABR at a median study duration of 30 weeks."
                            src="../etc.clientlibs/genentech-core/clientlibs/clientlib-site/resources/images/optimized-img-placeholder.png"
                            sizes="(max-width: 600px) 480px, 800px"
                            srcset="
                              /content/dam/gene/hemlibra-hcp/images/hemlibra-haven-1-intra-individual-comparison-data-chart-desktop.jpg 800w,
                              /content/dam/gene/hemlibra-hcp/images/hemlibra-haven-1-intra-individual-comparison-data-chart-mobile.jpg  480w,
                              /content/dam/gene/hemlibra-hcp/images/hemlibra-haven-1-intra-individual-comparison-data-chart-desktop.jpg 800w
                            "
                          />
                        </div>
                      </div>
                    </div>
                    <div class="text">
                      <div
                        class="cmp-text"
                        data-analytics-component="text"
                        data-table-stacked-on-mobile="false"
                        data-table-lock-first-column="false"
                      >
                        <ul>
                          <li>
                            Patients in the HAVEN 1 prophylactic intra-patient
                            comparison had a median duration on HEMLIBRA of 19
                            weeks
                          </li>
                          <li>
                            The duration on HEMLIBRA for patients with the 2
                            highest ABRs were 12.1 weeks (ABR: 39) and 6.9 weeks
                            (ABR: 23)
                          </li>
                        </ul>
                        <div>
                          <span class="footnote-text"
                            ><sup>†</sup>A comparison of data from HAVEN 1 vs
                            data in the NIS prior to enrollment.</span
                          >
                        </div>
                        <h3>
                          Patients reported improvement in painful swellings and
                          mobility<sup><span class="reference">1</span></sup>
                        </h3>
                        <h4>
                          HAVEN 1 prespecified endpoint<sup>‡</sup>: Haem-A-QoL
                          physical health score at 25 weeks
                        </h4>
                      </div>
                    </div>
                    <div
                      class="
                        container
                        responsivegrid
                        callout callout--basic-squared
                      "
                    >
                      <div class="cmp-container component-row">
                        <div class="cmp-container__inner content-container">
                          <div class="text">
                            <div
                              class="cmp-text"
                              data-analytics-component="text"
                              data-table-stacked-on-mobile="false"
                              data-table-lock-first-column="false"
                            >
                              <p>
                                <span class="h3"
                                  >Mean change in physical health score</span
                                >
                              </p>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                    <div class="columncontrol">
                      <div
                        class="
                          cmp-columncontrol
                          component-row
                          cmp-columncontrol--col2_50
                        "
                        data-analytics-component="columncontrol"
                      >
                        <div
                          class="cmp-columncontrol__column"
                          data-mobile-order="1"
                        >
                          <div class="container responsivegrid">
                            <div class="cmp-container component-row">
                              <div
                                class="cmp-container__inner content-container"
                              >
                                <div class="responsiveimage">
                                  <div
                                    data-analytics-component="responsiveimage"
                                    data-linktype="linkPath"
                                    class="cmp-responsiveimg comp-margin-bottom"
                                  >
                                    <div
                                      class="cmp-responsiveimg__inner"
                                      style="280"
                                    >
                                      <img
                                        class="cmp-responsiveimg__image"
                                        alt="Patient-reported physical health score."
                                        src="../etc.clientlibs/genentech-core/clientlibs/clientlib-site/resources/images/optimized-img-placeholder.png"
                                        sizes="(max-width: 600px) 480px, 800px"
                                        srcset="
                                          /content/dam/gene/hemlibra-hcp/images/hemlibra-haven-1-mean-change-physical-health-score-chart-desktop.jpg 800w,
                                          /content/dam/gene/hemlibra-hcp/images/hemlibra-haven-1-mean-change-physical-health-score-chart-mobile.jpg  480w,
                                          /content/dam/gene/hemlibra-hcp/images/hemlibra-haven-1-mean-change-physical-health-score-chart-desktop.jpg 800w
                                        "
                                      />
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>

                        <div
                          class="cmp-columncontrol__column"
                          data-mobile-order="2"
                        >
                          <div class="container responsivegrid">
                            <div class="cmp-container component-row">
                              <div
                                class="cmp-container__inner content-container"
                              >
                                <div class="text">
                                  <div
                                    class="cmp-text"
                                    data-analytics-component="text"
                                    data-table-stacked-on-mobile="false"
                                    data-table-lock-first-column="false"
                                  >
                                    <p>
                                      Physical health score vs no prophylaxis at
                                      Week 25 (21.6 difference in adjusted
                                      means<sup>‡</sup>; <i>P</i>=0.0029) of the
                                      Haem-A-QoL, which includes:
                                    </p>
                                    <ul>
                                      <li>
                                        Hemophilia-related symptoms (painful
                                        swellings and presence of joint pain)
                                      </li>
                                      <li>
                                        Physical functioning (pain without
                                        movement and difficulty walking far)
                                      </li>
                                    </ul>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                    <div class="text">
                      <div
                        class="cmp-text"
                        data-analytics-component="text"
                        data-table-stacked-on-mobile="false"
                        data-table-lock-first-column="false"
                      >
                        <p>
                          <span class="footnote-text"
                            ><sup>‡</sup>Patients aged 18 and up.<sup
                              ><span class="reference">5</span></sup
                            ><br />
                            ABR=annualized bleed rate. ABR calculated with a
                            negative binomial regression model, which accounts
                            for different follow-up times.<sup
                              ><span class="reference">15</span></sup
                            ></span
                          >
                        </p>
                      </div>
                    </div>
                    <div
                      class="
                        container
                        responsivegrid
                        callout callout--butter-knife
                      "
                    >
                      <div class="cmp-container component-row">
                        <div class="cmp-container__inner content-container">
                          <div class="text">
                            <div
                              class="cmp-text"
                              data-analytics-component="text"
                              data-table-stacked-on-mobile="false"
                              data-table-lock-first-column="false"
                            >
                              <p>
                                <span class="h4">Pediatric Patients</span><br />
                                Using HEMLIBRA in your pediatric patients with
                                or without inhibitors
                              </p>
                            </div>
                          </div>
                          <div class="button">
                            <a
                              class="
                                cmp-button
                                bttn bttn--primary bttn--circle
                                cmp-button
                              "
                              data-analytics-component="button"
                              href="pediatric-patients.html"
                              target="_self"
                              data-analytics='{\"component\":\"button\",\"destinationTitle\":\"see how\",\"location\":\"body\",\"destinationURL\":\"/trials-and-results/pediatric-patients.html\",\"type\":\"internal\"}'
                            >
                              <span class="cmp-button__text">see how</span>
                            </a>
                          </div>
                        </div>
                      </div>
                    </div>
                    <div class="text">
                      <div
                        class="cmp-text"
                        data-analytics-component="text"
                        data-table-stacked-on-mobile="false"
                        data-table-lock-first-column="false"
                      >
                        <p>
                          <span class="footnote-text"
                            >BPA=bypassing agent; CI=confidence interval;
                            FVIII=factor VIII; Haem-A-QoL=Haemophilia Quality of
                            Life Questionnaire for Adults;
                            NIS=non-interventional study; QW=once weekly.</span
                          >
                        </p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div
          class="experiencefragment aem-GridColumn aem-GridColumn--default--12"
        >
          <div
            class="cmp-experiencefragment"
            data-analytics-component="experiencefragment"
            data-analytics-location="safetybar"
          >
            <div class="xf-content-height">
              <div class="aem-Grid aem-Grid--12 aem-Grid--default--12">
                <div
                  class="
                    container
                    responsivegrid
                    aem-GridColumn aem-GridColumn--default--12
                  "
                >
                  <div id="safety" class="cmp-container component-row">
                    <div class="cmp-container__inner content-container">
                      <div class="safetybar">
                        <div
                          class="cmp-safetybar component-row"
                          data-analytics-component="safetybar"
                          data-small-height="180"
                          data-medium-height="160"
                        >
                          <div
                            class="
                              cmp-safetybar__sticky-wrapper
                              sticky-full-width
                            "
                          >
                            <div class="cmp-safetybar__inner-wrapper">
                              <div class="cmp-safetybar__header">
                                <div
                                  class="
                                    cmp-safetybar__header-inner
                                    content-container
                                  "
                                >
                                  <h4 class="cmp-safetybar__title">
                                    Indication &amp; Important Safety
                                    Information
                                  </h4>
                                  <div class="cmp-safetybar__buttons">
                                    <button
                                      class="
                                        button-reset
                                        cmp-safetybar__button-see-more
                                      "
                                    >
                                      See More
                                      <i class="fa fa-chevron-down"></i>
                                    </button>
                                    <button
                                      class="
                                        button-reset
                                        cmp-safetybar__button-top
                                      "
                                    >
                                      Back to Top
                                      <i class="fa fa-chevron-up"></i>
                                    </button>
                                  </div>
                                </div>
                              </div>
                              <div class="cmp-safetybar__body">
                                <div class="cmp-safetybar__content">
                                  <div
                                    class="
                                      cmp-safetybar__parsys1
                                      two-column
                                      content-container
                                    "
                                  >
                                    <div
                                      class="
                                        safetysnippetlist
                                        contentfragmentlist
                                        section
                                      "
                                    >
                                      <div
                                        class="
                                          cmp-safetysnippetlist
                                          component-row
                                        "
                                        data-analytics-component="safetysnippet"
                                      >
                                        <div
                                          class="
                                            cmp-safetysnippetlist__snippets
                                            cmp-safetysnippetlist__snippets--first
                                          "
                                        >
                                          <div
                                            class="cmp-safetysnippetlist__item"
                                            id="HCP_001_indication"
                                          >
                                            <div
                                              class="
                                                cmp-safetysnippetlist__item-richtext
                                              "
                                            >
                                              <p>
                                                <b>Indication<br /> </b
                                                >HEMLIBRA is indicated for
                                                routine prophylaxis to prevent
                                                or reduce the frequency of
                                                bleeding episodes in adult and
                                                pediatric patients ages newborn
                                                and older with hemophilia A with
                                                or without factor VIII
                                                inhibitors.
                                              </p>
                                            </div>
                                          </div>
                                        </div>

                                        <div
                                          class="
                                            cmp-safetysnippetlist__snippets
                                            cmp-safetysnippetlist__snippets--remaining
                                          "
                                        >
                                          <div
                                            class="cmp-safetysnippetlist__item"
                                            id="HCP_002_long_safety"
                                          >
                                            <div
                                              class="
                                                cmp-safetysnippetlist__item-richtext
                                              "
                                            >
                                              <p>
                                                <b
                                                  >Important Safety
                                                  Information<br />
                                                  Boxed WARNING: THROMBOTIC
                                                  MICROANGIOPATHY and
                                                  THROMBOEMBOLISM<br />
                                                  Cases of thrombotic
                                                  microangiopathy and thrombotic
                                                  events were reported when on
                                                  average a cumulative amount of
                                                  &gt;100 U/kg/24 hours of
                                                  activated prothrombin complex
                                                  concentrate (aPCC) was
                                                  administered for 24 hours or
                                                  more to patients receiving
                                                  HEMLIBRA prophylaxis. Monitor
                                                  for the development of
                                                  thrombotic microangiopathy and
                                                  thrombotic events if aPCC is
                                                  administered. Discontinue aPCC
                                                  and suspend dosing of HEMLIBRA
                                                  if symptoms occur. </b
                                                >
                                              </p>
                                              <p>
                                                <b
                                                  >Warnings and Precautions<br /> </b
                                                >Thrombotic Microangiopathy
                                                (TMA) and Thromboembolism
                                                Associated With HEMLIBRA and
                                                aPCC<br />
                                                In clinical trials, TMA was
                                                reported in 0.8% of patients
                                                (3/391) and thrombotic events
                                                were reported in 0.5% of
                                                patients (2/391). In patients
                                                who received at least one dose
                                                of aPCC, TMA was reported in
                                                8.1% of patients (3/37) and
                                                thrombotic events were reported
                                                in 5.4% of patients (2/37).
                                                Patients with TMA presented with
                                                thrombocytopenia,
                                                microangiopathic hemolytic
                                                anemia, and acute kidney injury,
                                                without severe deficiencies in
                                                ADAMTS13.
                                              </p>
                                              <p>
                                                Consider the benefits and risks
                                                if aPCC must be used in a
                                                patient receiving HEMLIBRA
                                                prophylaxis. Due to the long
                                                half-life of HEMLIBRA, the
                                                potential for an interaction
                                                with aPCC may persist for up to
                                                6 months after the last dose.
                                                Monitor for the development of
                                                TMA and/or thromboembolism when
                                                administering aPCC. Immediately
                                                discontinue aPCC and interrupt
                                                HEMLIBRA prophylaxis if clinical
                                                symptoms, imaging, or laboratory
                                                findings consistent with TMA
                                                and/or thromboembolism occur,
                                                and manage as clinically
                                                indicated. Consider the benefits
                                                and risks of resuming HEMLIBRA
                                                prophylaxis following complete
                                                resolution of TMA and/or
                                                thrombotic events on a
                                                case-by-case basis.
                                              </p>
                                              <p>
                                                Laboratory Coagulation Test
                                                Interference<br />
                                                HEMLIBRA affects intrinsic
                                                pathway clotting-based
                                                laboratory tests, including
                                                activated clotting time (ACT);
                                                activated partial thromboplastin
                                                time (aPTT); and all assays
                                                based on aPTT, such as
                                                one-stage, factor VIII (FVIII)
                                                activity. Therefore, intrinsic
                                                pathway clotting-based
                                                coagulation laboratory test
                                                results in patients who have
                                                been treated with HEMLIBRA
                                                prophylaxis should not be used
                                                to monitor HEMLIBRA activity,
                                                determine dosing for factor
                                                replacement or anti-coagulation,
                                                or measure FVIII inhibitor
                                                titers.
                                              </p>
                                              <p>
                                                Results affected by HEMLIBRA:
                                                aPTT; Bethesda assays
                                                (clotting-based) for FVIII
                                                inhibitor titers; one-stage,
                                                aPTT-based single-factor assays;
                                                aPTT-based Activated Protein C
                                                Resistance (APC-R); ACT.
                                              </p>
                                              <p>
                                                Results unaffected by HEMLIBRA:
                                                Bethesda assays (bovine
                                                chromogenic) for FVIII inhibitor
                                                titers; thrombin time (TT);
                                                one-stage, prothrombin time
                                                (PT)-based single-factor assays;
                                                chromogenic-based single-factor
                                                assays other than FVIII (see
                                                Drug Interactions for FVIII
                                                chromogenic activity assay
                                                considerations); immuno-based
                                                assays (ie, ELISA, turbidimetric
                                                methods); genetic tests of
                                                coagulation factors (eg, Factor
                                                V Leiden, Prothrombin 20210).
                                              </p>
                                              <p>
                                                <b
                                                  >Most Common Adverse
                                                  Reactions</b
                                                ><br />
                                                The most common adverse
                                                reactions (incidence ≥10%) are
                                                injection site reactions,
                                                headache, and arthralgia.
                                              </p>
                                              <p>
                                                <b>Adverse Reactions</b><br />
                                                Characterization of aPCC
                                                Treatment in Pooled Clinical
                                                Trials<br />
                                                There were 130 instances of aPCC
                                                treatment in 37 patients, of
                                                which 13 instances (10%)
                                                consisted of on average a
                                                cumulative amount of &gt;100
                                                U/kg/24 hours of aPCC for 24
                                                hours or more; 2 of the 13 were
                                                associated with thrombotic
                                                events and 3 of the 13 were
                                                associated with TMA. No TMA or
                                                thrombotic events were
                                                associated with the remaining
                                                instances of aPCC treatment.
                                              </p>
                                              <p>
                                                Injection Site Reactions<br />
                                                In total, 85 patients (22%)
                                                reported injection site
                                                reactions (ISRs). All ISRs
                                                observed in HEMLIBRA clinical
                                                trials were reported as mild to
                                                moderate intensity and 93%
                                                resolved without treatment. The
                                                commonly reported ISR symptoms
                                                were injection site erythema
                                                (11%), injection site pruritus
                                                (4%), and injection site pain
                                                (4%).
                                              </p>
                                              <p>
                                                Other Less Common (&lt;1%)
                                                Reactions<br />
                                                Rhabdomyolysis was reported in 2
                                                adult patients with asymptomatic
                                                elevations in serum creatine
                                                kinase without associated renal
                                                or musculoskeletal symptoms. In
                                                both instances, the event
                                                occurred following an increase
                                                in physical activity.
                                              </p>
                                              <p>
                                                <b>Drug Interactions</b><br />
                                                Clinical experience suggests
                                                that a drug interaction exists
                                                with HEMLIBRA and aPCC.
                                              </p>
                                              <p>
                                                <b
                                                  >Pregnancy, Lactation, Females
                                                  and Males of Reproductive
                                                  Potential</b
                                                ><br />
                                                Women of childbearing potential
                                                should use contraception while
                                                receiving HEMLIBRA. It is not
                                                known whether HEMLIBRA can cause
                                                fetal harm when administered to
                                                a pregnant woman or can affect
                                                reproduction capacity. HEMLIBRA
                                                should be used during pregnancy
                                                only if the potential benefit
                                                for the mother outweighs the
                                                risk to the fetus. The
                                                developmental and health
                                                benefits of breastfeeding should
                                                be considered along with the
                                                mother’s clinical need for
                                                HEMLIBRA and any potential
                                                adverse effects on the breastfed
                                                child from HEMLIBRA or from the
                                                underlying maternal condition.
                                              </p>
                                              <p>
                                                You may report side effects to
                                                the FDA at
                                                <a
                                                  href="tel:18003321088"
                                                  data-analytics='{\"component\":\"safetysnippet\",\"destinationTitle\":\"(800) FDA-1088\",\"location\":\"safetybar\",\"destinationURL\":\"tel:18003321088\",\"type\":\"external\"}'
                                                  >(800) FDA-1088</a
                                                >
                                                or
                                                <a
                                                  href="../safety/medwatch-fda-safety-information-and-adverse-event-reporting-program.html"
                                                  target="_blank"
                                                  data-analytics='{\"component\":\"safetysnippet\",\"destinationTitle\":\"www.fda.gov/medwatch\",\"location\":\"safetybar\",\"destinationURL\":\"https://www.fda.gov/medwatch\",\"type\":\"external\"}'
                                                  >www.fda.gov/medwatch</a
                                                >. You may also report side
                                                effects to Genentech at
                                                <a
                                                  href="tel:18888352555"
                                                  data-analytics='{\"component\":\"safetysnippet\",\"destinationTitle\":\"(888) 835-2555\",\"location\":\"safetybar\",\"destinationURL\":\"tel:18888352555\",\"type\":\"external\"}'
                                                  >(888) 835-2555</a
                                                >.
                                              </p>
                                              <p>
                                                Please see the HEMLIBRA full
                                                <a
                                                  href="../download/pdf/hemlibra_prescribing.pdf"
                                                  target="_blank"
                                                  data-analytics='{\"component\":\"safetysnippet\",\"destinationTitle\":\"Prescribing Information\",\"location\":\"safetybar\",\"destinationURL\":\"https://www.gene.com/download/pdf/hemlibra_prescribing.pdf\",\"type\":\"external\"}'
                                                  >Prescribing Information</a
                                                >
                                                for additional Important Safety
                                                Information, including
                                                <b>Boxed WARNING</b>.<br />
                                              </p>
                                            </div>
                                          </div>
                                        </div>
                                      </div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <div
          class="experiencefragment aem-GridColumn aem-GridColumn--default--12"
        >
          <div
            class="cmp-experiencefragment"
            data-analytics-component="experiencefragment"
            data-analytics-location="footer"
          >
            <div class="xf-content-height">
              <div class="aem-Grid aem-Grid--12 aem-Grid--default--12">
                <div
                  class="
                    container
                    responsivegrid
                    aem-GridColumn aem-GridColumn--default--12
                  "
                >
                  <div class="cmp-container component-row">
                    <div class="cmp-container__inner content-container">
                      <div class="container responsivegrid">
                        <div class="cmp-container component-row">
                          <div class="cmp-container__inner content-container">
                            <div class="experiencefragment">
                              <div
                                class="cmp-experiencefragment"
                                data-analytics-component="experiencefragment"
                              >
                                <div class="xf-content-height">
                                  <div
                                    class="
                                      aem-Grid
                                      aem-Grid--12
                                      aem-Grid--default--12
                                    "
                                  >
                                    <div
                                      class="
                                        container
                                        responsivegrid
                                        aem-GridColumn
                                        aem-GridColumn--default--12
                                      "
                                    >
                                      <div class="cmp-container component-row">
                                        <div
                                          class="
                                            cmp-container__inner
                                            content-container
                                          "
                                        >
                                          <div class="references">
                                            <div
                                              class="cmp-references"
                                              data-analytics-component="references"
                                              data-singular-heading="Reference:"
                                              data-plural-heading="References:"
                                            >
                                              <div
                                                class="cmp-references__title"
                                              ></div>
                                              <ul class="cmp-references__list">
                                                <li
                                                  class="
                                                    cmp-references__list-column
                                                    cmp-references__list-column--1
                                                  "
                                                >
                                                  <ul>
                                                    <li
                                                      id="33d05637-5700-470a-a58c-907ac7671c1a"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="1"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Data on file.
                                                          Genentech, Inc.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-1"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Data on file.
                                                              Genentech, Inc.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="58c0f58e-9d34-4f9b-9c38-5b784e611cb2"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="2"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Our commitment to
                                                          provide transparent
                                                          and timely safety
                                                          information about
                                                          emicizumab-kxwh.
                                                          Genentech, Inc.
                                                          <a
                                                            href="https://www.emicizumabinfo.com/content/emicizumabinfo/en_us/patient.html#"
                                                            target="_blank"
                                                            data-analytics='{\"component\":\"references\",\"destinationTitle\":\"https://www.emicizumabinfo.com/content/emicizumabinfo/en_us/patient.html#\",\"location\":\"footer\",\"destinationURL\":\"https://www.emicizumabinfo.com/content/emicizumabinfo/en_us/patient.html#\",\"type\":\"external\"}'
                                                            >https://www.emicizumabinfo.com/content/emicizumabinfo/en_us/patient.html#</a
                                                          >. Accessed August 25,
                                                          2020.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-2"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Our commitment to
                                                              provide
                                                              transparent and
                                                              timely safety
                                                              information about
                                                              emicizumab-kxwh.
                                                              Genentech, Inc.
                                                              <a
                                                                href="https://www.emicizumabinfo.com/content/emicizumabinfo/en_us/patient.html#"
                                                                target="_blank"
                                                                data-analytics='{\"component\":\"references\",\"destinationTitle\":\"https://www.emicizumabinfo.com/content/emicizumabinfo/en_us/patient.html#\",\"location\":\"footer\",\"destinationURL\":\"https://www.emicizumabinfo.com/content/emicizumabinfo/en_us/patient.html#\",\"type\":\"external\"}'
                                                                >https://www.emicizumabinfo.com/content/emicizumabinfo/en_us/patient.html#</a
                                                              >. Accessed August
                                                              25, 2020.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="802c5e21-be08-439d-9504-7358315fb393"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="3"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Chugai Pharmaceutical
                                                          Co., Ltd. Randomized,
                                                          placebo-controlled,
                                                          double-blind, single
                                                          ascending dose study
                                                          and open-label
                                                          multiple ascending
                                                          dose study.
                                                          <a
                                                            href="../cti-user/trial/ShowDirect.jsp.html?japicId=JapicCTI-121934"
                                                            target="_blank"
                                                            data-analytics='{\"component\":\"references\",\"destinationTitle\":\"https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-121934\",\"location\":\"footer\",\"destinationURL\":\"https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-121934\",\"type\":\"external\"}'
                                                            >https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-121934</a
                                                          >. Main ID:
                                                          JPRN-JapicCTI-121934.
                                                          Accessed August 25,
                                                          2020.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-3"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Chugai
                                                              Pharmaceutical
                                                              Co., Ltd.
                                                              Randomized,
                                                              placebo-controlled,
                                                              double-blind,
                                                              single ascending
                                                              dose study and
                                                              open-label
                                                              multiple ascending
                                                              dose study.
                                                              <a
                                                                href="../cti-user/trial/ShowDirect.jsp.html?japicId=JapicCTI-121934"
                                                                target="_blank"
                                                                data-analytics='{\"component\":\"references\",\"destinationTitle\":\"https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-121934\",\"location\":\"footer\",\"destinationURL\":\"https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-121934\",\"type\":\"external\"}'
                                                                >https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-121934</a
                                                              >. Main ID:
                                                              JPRN-JapicCTI-121934.
                                                              Accessed August
                                                              25, 2020.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="31e8f9f7-f4d3-4853-bd8b-4813b4933ec9"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="4"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Chugai Pharmaceutical
                                                          Co., Ltd. Extension
                                                          study of the phase 1
                                                          study of ACE910.
                                                          <a
                                                            href="../cti-user/trial/ShowDirect.jsp-1.html?japicId=JapicCTI-132195"
                                                            target="_blank"
                                                            data-analytics='{\"component\":\"references\",\"destinationTitle\":\"https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-132195\",\"location\":\"footer\",\"destinationURL\":\"https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-132195\",\"type\":\"external\"}'
                                                            >https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-132195</a
                                                          >. Main ID:
                                                          JPRN-JapicCTI-132195.
                                                          Accessed August 25,
                                                          2020.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-4"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Chugai
                                                              Pharmaceutical
                                                              Co., Ltd.
                                                              Extension study of
                                                              the phase 1 study
                                                              of ACE910.
                                                              <a
                                                                href="../cti-user/trial/ShowDirect.jsp-1.html?japicId=JapicCTI-132195"
                                                                target="_blank"
                                                                data-analytics='{\"component\":\"references\",\"destinationTitle\":\"https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-132195\",\"location\":\"footer\",\"destinationURL\":\"https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-132195\",\"type\":\"external\"}'
                                                                >https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-132195</a
                                                              >. Main ID:
                                                              JPRN-JapicCTI-132195.
                                                              Accessed August
                                                              25, 2020.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="78045b66-50dd-4c83-b5ae-dcead3c60470"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="5"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          HEMLIBRA [package
                                                          insert]. South San
                                                          Francisco, CA:
                                                          Genentech, Inc.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-5"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              HEMLIBRA [package
                                                              insert]. South San
                                                              Francisco, CA:
                                                              Genentech, Inc.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="8debbaea-5f27-49fb-a495-27a0b0ab1142"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="6"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          National Hemophilia
                                                          Foundation. MASAC
                                                          update on the approval
                                                          and availability of
                                                          the new treatment:
                                                          Emicizumab (HEMLIBRA),
                                                          for persons with
                                                          hemophilia A with
                                                          inhibitors to factor
                                                          VIII: Interim guidance
                                                          on acute bleed
                                                          management and use of
                                                          laboratory assays.
                                                          November 24, 2017; New
                                                          York, NY.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-6"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              National
                                                              Hemophilia
                                                              Foundation. MASAC
                                                              update on the
                                                              approval and
                                                              availability of
                                                              the new treatment:
                                                              Emicizumab
                                                              (HEMLIBRA), for
                                                              persons with
                                                              hemophilia A with
                                                              inhibitors to
                                                              factor VIII:
                                                              Interim guidance
                                                              on acute bleed
                                                              management and use
                                                              of laboratory
                                                              assays. November
                                                              24, 2017; New
                                                              York, NY.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="2006fa93-f467-4701-a949-953185149d80"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="7"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Kitazawa T, Esaki K,
                                                          Tachibana T, et al.
                                                          Factor VIIIa-mimetic
                                                          cofactor activity of a
                                                          bispecific antibody to
                                                          factors IX/IXa and
                                                          X/Xa, emicizumab,
                                                          depends on its ability
                                                          to bridge the
                                                          antigens. <i
                                                            >Thromb Haemost</i
                                                          >. 2017;117(7):1348-1357.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-7"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Kitazawa T, Esaki
                                                              K, Tachibana T, et
                                                              al. Factor
                                                              VIIIa-mimetic
                                                              cofactor activity
                                                              of a bispecific
                                                              antibody to
                                                              factors IX/IXa and
                                                              X/Xa, emicizumab,
                                                              depends on its
                                                              ability to bridge
                                                              the antigens. <i
                                                                >Thromb
                                                                Haemost</i
                                                              >. 2017;117(7):1348-1357.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="1dcf0745-3014-4ad4-ad85-1f369e0b5d01"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="8"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Young G, Liesner R,
                                                          Chang T, et al. A
                                                          multicenter,
                                                          open-label phase 3
                                                          study of emicizumab
                                                          prophylaxis in
                                                          children with
                                                          hemophilia A with
                                                          inhibitors.
                                                          <i>Blood</i>.
                                                          2019;134(24):2127-2138.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-8"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Young G, Liesner
                                                              R, Chang T, et al.
                                                              A multicenter,
                                                              open-label phase 3
                                                              study of
                                                              emicizumab
                                                              prophylaxis in
                                                              children with
                                                              hemophilia A with
                                                              inhibitors.
                                                              <i>Blood</i>.
                                                              2019;134(24):2127-2138.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="dbea68a7-3657-41e7-b309-702ae67d6e72"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="9"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Shima M, Hanabusa H,
                                                          Taki M, et al.
                                                          Long-term safety and
                                                          efficacy of emicizumab
                                                          in a phase 1/2 study
                                                          in patients with
                                                          hemophilia A with or
                                                          without inhibitors.
                                                          <i>Blood Adv</i>.
                                                          2017;1(22):1891-1899.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-9"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Shima M, Hanabusa
                                                              H, Taki M, et al.
                                                              Long-term safety
                                                              and efficacy of
                                                              emicizumab in a
                                                              phase 1/2 study in
                                                              patients with
                                                              hemophilia A with
                                                              or without
                                                              inhibitors.
                                                              <i>Blood Adv</i>.
                                                              2017;1(22):1891-1899.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="dbb1034a-2f97-4e22-8e73-a31ac961b294"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="10"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Shima M, Nagao A,
                                                          Masashi T, et al.
                                                          Long-term safety and
                                                          efficacy of emicizumab
                                                          for up to &gt;5 years
                                                          in a phase 1/2 study
                                                          in patients with
                                                          severe hemophilia A.
                                                          Poster presented at:
                                                          International Society
                                                          on Thrombosis and
                                                          Haemostasis 2020
                                                          Virtual Congress; July
                                                          12–14, 2020.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-10"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Shima M, Nagao A,
                                                              Masashi T, et al.
                                                              Long-term safety
                                                              and efficacy of
                                                              emicizumab for up
                                                              to &gt;5 years in
                                                              a phase 1/2 study
                                                              in patients with
                                                              severe hemophilia
                                                              A. Poster
                                                              presented at:
                                                              International
                                                              Society on
                                                              Thrombosis and
                                                              Haemostasis 2020
                                                              Virtual Congress;
                                                              July 12–14, 2020.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="27bf5bd0-9fd5-40c2-952a-481cf3fa1039"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="11"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Wang S, Zhao X, Wang
                                                          X, et al. A
                                                          randomized,
                                                          multicenter,
                                                          open-label, phase III
                                                          clinical trial to
                                                          evaluate the efficacy,
                                                          safety, and
                                                          pharmacokinetics of
                                                          prophylactic
                                                          emicizumab versus no
                                                          prophylaxis in persons
                                                          with hemophilia A in
                                                          the Asia-Pacific
                                                          region (HAVEN 5).
                                                          Poster presented at:
                                                          International Society
                                                          on Thrombosis and
                                                          Haemostasis 2020
                                                          Virtual Congress; July
                                                          12–14, 2020.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-11"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Wang S, Zhao X,
                                                              Wang X, et al. A
                                                              randomized,
                                                              multicenter,
                                                              open-label, phase
                                                              III clinical trial
                                                              to evaluate the
                                                              efficacy, safety,
                                                              and
                                                              pharmacokinetics
                                                              of prophylactic
                                                              emicizumab versus
                                                              no prophylaxis in
                                                              persons with
                                                              hemophilia A in
                                                              the Asia-Pacific
                                                              region (HAVEN 5).
                                                              Poster presented
                                                              at: International
                                                              Society on
                                                              Thrombosis and
                                                              Haemostasis 2020
                                                              Virtual Congress;
                                                              July 12–14, 2020.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="28938a70-e68a-4496-9ed2-a576cca97105"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="12"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Shima M, Nogami K,
                                                          Nagami S, et al. A
                                                          multicentre,
                                                          open-label study of
                                                          emicizumab given every
                                                          2 or 4 weeks in
                                                          children with severe
                                                          haemophilia A without
                                                          inhibitors.
                                                          <i>Haemophilia</i>.
                                                          2019;25(6):979-987.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-12"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Shima M, Nogami K,
                                                              Nagami S, et al. A
                                                              multicentre,
                                                              open-label study
                                                              of emicizumab
                                                              given every 2 or 4
                                                              weeks in children
                                                              with severe
                                                              haemophilia A
                                                              without
                                                              inhibitors.
                                                              <i>Haemophilia</i
                                                              >.
                                                              2019;25(6):979-987.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="d63b0a03-1bfe-4217-b946-f20b689ad499"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="13"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Jiménez-Yuste V,
                                                          Klamroth R, Castaman
                                                          G, et al. Second
                                                          interim analysis
                                                          results from the
                                                          STASEY trial: a
                                                          single-arm,
                                                          multicenter,
                                                          open-label, phase III
                                                          clinical trial to
                                                          evaluate the safety
                                                          and tolerability of
                                                          emicizumab prophylaxis
                                                          in people with
                                                          hemophilia A (PwHA)
                                                          with FVIII inhibitors.
                                                          Poster presented at:
                                                          International Society
                                                          on Thrombosis and
                                                          Haemostasis 2020
                                                          Virtual Congress; July
                                                          12–14, 2020.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-13"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Jiménez-Yuste V,
                                                              Klamroth R,
                                                              Castaman G, et al.
                                                              Second interim
                                                              analysis results
                                                              from the STASEY
                                                              trial: a
                                                              single-arm,
                                                              multicenter,
                                                              open-label, phase
                                                              III clinical trial
                                                              to evaluate the
                                                              safety and
                                                              tolerability of
                                                              emicizumab
                                                              prophylaxis in
                                                              people with
                                                              hemophilia A
                                                              (PwHA) with FVIII
                                                              inhibitors. Poster
                                                              presented at:
                                                              International
                                                              Society on
                                                              Thrombosis and
                                                              Haemostasis 2020
                                                              Virtual Congress;
                                                              July 12–14, 2020.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="dbafd3c3-0cb0-40d8-9f23-cf77853de078"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="14"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Callaghan M, Negrier
                                                          C, Paz-Priel I, et al.
                                                          Emicizumab treatment
                                                          is efficacious and
                                                          well tolerated long
                                                          term in persons with
                                                          haemophilia (PwHA)
                                                          with or without FVIII
                                                          inhibitors: pooled
                                                          data from four HAVEN
                                                          studies. Slide deck
                                                          presented at:
                                                          International Society
                                                          on Thrombosis and
                                                          Haemostasis 2019
                                                          Congress; July 6–10,
                                                          2019; Melbourne,
                                                          Australia.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-14"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Callaghan M,
                                                              Negrier C,
                                                              Paz-Priel I, et
                                                              al. Emicizumab
                                                              treatment is
                                                              efficacious and
                                                              well tolerated
                                                              long term in
                                                              persons with
                                                              haemophilia (PwHA)
                                                              with or without
                                                              FVIII inhibitors:
                                                              pooled data from
                                                              four HAVEN
                                                              studies. Slide
                                                              deck presented at:
                                                              International
                                                              Society on
                                                              Thrombosis and
                                                              Haemostasis 2019
                                                              Congress; July
                                                              6–10, 2019;
                                                              Melbourne,
                                                              Australia.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="0f09fb35-8470-482d-8a0d-755bdd29ea40"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="15"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Oldenburg J, Mahlangu
                                                          JN, Kim B, et al.
                                                          Emicizumab prophylaxis
                                                          in hemophilia A with
                                                          inhibitors.
                                                          <i>N Engl J Med</i>.
                                                          2017;377(9):809-818.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-15"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Oldenburg J,
                                                              Mahlangu JN, Kim
                                                              B, et al.
                                                              Emicizumab
                                                              prophylaxis in
                                                              hemophilia A with
                                                              inhibitors.
                                                              <i>N Engl J Med</i
                                                              >.
                                                              2017;377(9):809-818.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="152d7154-fc8c-40e1-830b-cfc5e3475823"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="16"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Young G, Liesner R,
                                                          Sidonio R Jr, et al.
                                                          Emicizumab prophylaxis
                                                          provides flexible and
                                                          effective bleed
                                                          control in children
                                                          with hemophilia A with
                                                          inhibitors: results
                                                          from the HAVEN 2
                                                          study. Presented at:
                                                          ASH 60th Annual
                                                          Meeting of the
                                                          American Society of
                                                          Hematology; December
                                                          1–4, 2018; San Diego,
                                                          CA.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-16"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Young G, Liesner
                                                              R, Sidonio R Jr,
                                                              et al. Emicizumab
                                                              prophylaxis
                                                              provides flexible
                                                              and effective
                                                              bleed control in
                                                              children with
                                                              hemophilia A with
                                                              inhibitors:
                                                              results from the
                                                              HAVEN 2 study.
                                                              Presented at: ASH
                                                              60th Annual
                                                              Meeting of the
                                                              American Society
                                                              of Hematology;
                                                              December 1–4,
                                                              2018; San Diego,
                                                              CA.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="b14fb8e1-3a6b-412b-aebd-0289715e114a"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="17"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Di Minno A, Spadarella
                                                          G, Nardone A, et al.
                                                          Attempting to remedy
                                                          sub-optimal medication
                                                          adherence in
                                                          haemophilia: the
                                                          rationale for repeated
                                                          ultrasound
                                                          visualisations of the
                                                          patient’s joint
                                                          status.
                                                          <i>Blood Rev</i>.
                                                          2019;33:106-119.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-17"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Di Minno A,
                                                              Spadarella G,
                                                              Nardone A, et al.
                                                              Attempting to
                                                              remedy sub-optimal
                                                              medication
                                                              adherence in
                                                              haemophilia: the
                                                              rationale for
                                                              repeated
                                                              ultrasound
                                                              visualisations of
                                                              the patient’s
                                                              joint status.
                                                              <i>Blood Rev</i>.
                                                              2019;33:106-119.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="423213a1-f6f4-4091-9f9d-60942f920caf"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="18"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Rocino A, Franchini M,
                                                          Coppola A. Treatment
                                                          and prevention of
                                                          bleeds in haemophilia
                                                          patients with
                                                          inhibitors to factor
                                                          VIII/IX.
                                                          <i>J Clin Med</i>.
                                                          2017;6(4):46.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-18"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Rocino A,
                                                              Franchini M,
                                                              Coppola A.
                                                              Treatment and
                                                              prevention of
                                                              bleeds in
                                                              haemophilia
                                                              patients with
                                                              inhibitors to
                                                              factor VIII/IX.
                                                              <i>J Clin Med</i>.
                                                              2017;6(4):46.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="07b3635b-da29-4893-93fb-d7c1928de3db"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="19"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Schrijvers LH,
                                                          Schuurmans MJ, Fischer
                                                          K. Promoting
                                                          self-management and
                                                          adherence during
                                                          prophylaxis:
                                                          evidence-based
                                                          recommendations for
                                                          haemophilia
                                                          professionals.
                                                          <i>Haemophilia</i>.
                                                          2016;22(4):499-506.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-19"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Schrijvers LH,
                                                              Schuurmans MJ,
                                                              Fischer K.
                                                              Promoting
                                                              self-management
                                                              and adherence
                                                              during
                                                              prophylaxis:
                                                              evidence-based
                                                              recommendations
                                                              for haemophilia
                                                              professionals.
                                                              <i>Haemophilia</i
                                                              >.
                                                              2016;22(4):499-506.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="c36530a1-95eb-4637-af4b-acc4f2eeb469"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="20"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Manco-Johnson MM,
                                                          Abshire TC, Shapiro
                                                          AD, et al. Prophylaxis
                                                          versus episodic
                                                          treatment to prevent
                                                          joint disease in boys
                                                          with severe
                                                          hemophilia.
                                                          <i>N Engl J Med</i>.
                                                          2007;357(6):535-544.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-20"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Manco-Johnson MM,
                                                              Abshire TC,
                                                              Shapiro AD, et al.
                                                              Prophylaxis versus
                                                              episodic treatment
                                                              to prevent joint
                                                              disease in boys
                                                              with severe
                                                              hemophilia.
                                                              <i>N Engl J Med</i
                                                              >.
                                                              2007;357(6):535-544.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="c0838d12-4da9-4741-b255-74e5ff3a51da"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="21"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          National Hemophilia
                                                          Foundation.
                                                          Recommendation on the
                                                          use and management of
                                                          emicizumab-kxwh
                                                          (HEMLIBRA<sup>®</sup>)
                                                          for hemophilia A with
                                                          and without
                                                          inhibitors. December
                                                          6, 2018; New York, NY.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-21"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              National
                                                              Hemophilia
                                                              Foundation.
                                                              Recommendation on
                                                              the use and
                                                              management of
                                                              emicizumab-kxwh
                                                              (HEMLIBRA<sup>®</sup>)
                                                              for hemophilia A
                                                              with and without
                                                              inhibitors.
                                                              December 6, 2018;
                                                              New York, NY.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="230388bf-0521-413c-96d1-5aaea1a40214"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="22"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          FDA approves
                                                          Genentech’s HEMLIBRA
                                                          (emicizumab-kxwh) for
                                                          hemophilia A without
                                                          factor VIII
                                                          inhibitors. [press
                                                          release]. South San
                                                          Francisco, CA:
                                                          Genentech; October 4,
                                                          2018.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-22"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              FDA approves
                                                              Genentech’s
                                                              HEMLIBRA
                                                              (emicizumab-kxwh)
                                                              for hemophilia A
                                                              without factor
                                                              VIII inhibitors.
                                                              [press release].
                                                              South San
                                                              Francisco, CA:
                                                              Genentech; October
                                                              4, 2018.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="08741395-cf25-485a-8db7-530628dc4509"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="23"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Hoffmann-La Roche. A
                                                          study to evaluate the
                                                          efficacy, safety, and
                                                          pharmacokinetics of
                                                          prophylactic
                                                          emicizumab versus no
                                                          prophylaxis in
                                                          hemophilia A
                                                          participants with
                                                          inhibitors (HAVEN 1).
                                                          <a
                                                            href="../ct2/show/NCT02622321.html"
                                                            target="_blank"
                                                            data-analytics='{\"component\":\"references\",\"destinationTitle\":\"https://clinicaltrials.gov/ct2/show/NCT02622321\",\"location\":\"footer\",\"destinationURL\":\"https://clinicaltrials.gov/ct2/show/NCT02622321\",\"type\":\"external\"}'
                                                            >https://clinicaltrials.gov/ct2/show/NCT02622321</a
                                                          >. NLM identifier:
                                                          NCT02622321. Accessed
                                                          August 25, 2020.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-23"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Hoffmann-La Roche.
                                                              A study to
                                                              evaluate the
                                                              efficacy, safety,
                                                              and
                                                              pharmacokinetics
                                                              of prophylactic
                                                              emicizumab versus
                                                              no prophylaxis in
                                                              hemophilia A
                                                              participants with
                                                              inhibitors (HAVEN
                                                              1).
                                                              <a
                                                                href="../ct2/show/NCT02622321.html"
                                                                target="_blank"
                                                                data-analytics='{\"component\":\"references\",\"destinationTitle\":\"https://clinicaltrials.gov/ct2/show/NCT02622321\",\"location\":\"footer\",\"destinationURL\":\"https://clinicaltrials.gov/ct2/show/NCT02622321\",\"type\":\"external\"}'
                                                                >https://clinicaltrials.gov/ct2/show/NCT02622321</a
                                                              >. NLM identifier:
                                                              NCT02622321.
                                                              Accessed August
                                                              25, 2020.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="a018dbf4-6a64-490f-abd0-2b5e6d4f61d2"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="24"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Hoffmann-La Roche. A
                                                          study of emicizumab
                                                          administered
                                                          subcutaneously (SC) in
                                                          pediatric participants
                                                          with hemophilia A and
                                                          factor VIII (FVIII)
                                                          inhibitors (HAVEN 2).
                                                          <a
                                                            href="../ct2/show/NCT02795767.html"
                                                            target="_blank"
                                                            data-analytics='{\"component\":\"references\",\"destinationTitle\":\"https://clinicaltrials.gov/ct2/show/NCT02795767\",\"location\":\"footer\",\"destinationURL\":\"https://clinicaltrials.gov/ct2/show/NCT02795767\",\"type\":\"external\"}'
                                                            >https://clinicaltrials.gov/ct2/show/NCT02795767</a
                                                          >. NLM identifier:
                                                          NCT02795767. Accessed
                                                          August 25, 2020.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-24"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Hoffmann-La Roche.
                                                              A study of
                                                              emicizumab
                                                              administered
                                                              subcutaneously
                                                              (SC) in pediatric
                                                              participants with
                                                              hemophilia A and
                                                              factor VIII
                                                              (FVIII) inhibitors
                                                              (HAVEN 2).
                                                              <a
                                                                href="../ct2/show/NCT02795767.html"
                                                                target="_blank"
                                                                data-analytics='{\"component\":\"references\",\"destinationTitle\":\"https://clinicaltrials.gov/ct2/show/NCT02795767\",\"location\":\"footer\",\"destinationURL\":\"https://clinicaltrials.gov/ct2/show/NCT02795767\",\"type\":\"external\"}'
                                                                >https://clinicaltrials.gov/ct2/show/NCT02795767</a
                                                              >. NLM identifier:
                                                              NCT02795767.
                                                              Accessed August
                                                              25, 2020.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="16c258d0-0dc1-4471-819f-562296cc3515"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="25"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Hoffmann-La Roche. A
                                                          clinical trial to
                                                          evaluate prophylactic
                                                          emicizumab versus no
                                                          prophylaxis in
                                                          hemophilia A
                                                          participants without
                                                          inhibitors (HAVEN 3).
                                                          <a
                                                            href="../ct2/show/NCT02847637.html"
                                                            target="_blank"
                                                            data-analytics='{\"component\":\"references\",\"destinationTitle\":\"https://clinicaltrials.gov/ct2/show/NCT02847637\",\"location\":\"footer\",\"destinationURL\":\"https://clinicaltrials.gov/ct2/show/NCT02847637\",\"type\":\"external\"}'
                                                            >https://clinicaltrials.gov/ct2/show/NCT02847637</a
                                                          >. NLM identifier:
                                                          NCT02847637. Accessed
                                                          August 25, 2020.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-25"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Hoffmann-La Roche.
                                                              A clinical trial
                                                              to evaluate
                                                              prophylactic
                                                              emicizumab versus
                                                              no prophylaxis in
                                                              hemophilia A
                                                              participants
                                                              without inhibitors
                                                              (HAVEN 3).
                                                              <a
                                                                href="../ct2/show/NCT02847637.html"
                                                                target="_blank"
                                                                data-analytics='{\"component\":\"references\",\"destinationTitle\":\"https://clinicaltrials.gov/ct2/show/NCT02847637\",\"location\":\"footer\",\"destinationURL\":\"https://clinicaltrials.gov/ct2/show/NCT02847637\",\"type\":\"external\"}'
                                                                >https://clinicaltrials.gov/ct2/show/NCT02847637</a
                                                              >. NLM identifier:
                                                              NCT02847637.
                                                              Accessed August
                                                              25, 2020.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="aaf91484-6b66-41af-bb61-6be6e35cdc80"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="26"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Hoffmann-La Roche. A
                                                          study to evaluate the
                                                          efficacy, safety,
                                                          pharmacokinetics, and
                                                          pharmacodynamics of
                                                          emicizumab given every
                                                          4 weeks in
                                                          participants with
                                                          hemophilia A (HAVEN
                                                          4).
                                                          <a
                                                            href="../ct2/show/NCT03020160.html"
                                                            target="_blank"
                                                            data-analytics='{\"component\":\"references\",\"destinationTitle\":\"https://clinicaltrials.gov/ct2/show/NCT03020160\",\"location\":\"footer\",\"destinationURL\":\"https://clinicaltrials.gov/ct2/show/NCT03020160\",\"type\":\"external\"}'
                                                            >https://clinicaltrials.gov/ct2/show/NCT03020160</a
                                                          >. NLM identifier:
                                                          NCT03020160. Accessed
                                                          August 25, 2020.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-26"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Hoffmann-La Roche.
                                                              A study to
                                                              evaluate the
                                                              efficacy, safety,
                                                              pharmacokinetics,
                                                              and
                                                              pharmacodynamics
                                                              of emicizumab
                                                              given every 4
                                                              weeks in
                                                              participants with
                                                              hemophilia A
                                                              (HAVEN 4).
                                                              <a
                                                                href="../ct2/show/NCT03020160.html"
                                                                target="_blank"
                                                                data-analytics='{\"component\":\"references\",\"destinationTitle\":\"https://clinicaltrials.gov/ct2/show/NCT03020160\",\"location\":\"footer\",\"destinationURL\":\"https://clinicaltrials.gov/ct2/show/NCT03020160\",\"type\":\"external\"}'
                                                                >https://clinicaltrials.gov/ct2/show/NCT03020160</a
                                                              >. NLM identifier:
                                                              NCT03020160.
                                                              Accessed August
                                                              25, 2020.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="593b993f-a335-42bc-bef8-dd670d4174ea"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="27"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Kruse-Jarres R,
                                                          Callaghan MU, Croteau
                                                          SE, et al. Surgical
                                                          experience in two
                                                          multicenter,
                                                          open-label phase 3
                                                          studies of emicizumab
                                                          in persons with
                                                          hemophilia A with
                                                          inhibitors (HAVEN 1
                                                          and HAVEN 2)
                                                          [abstract]. Presented
                                                          at: 59th Annual
                                                          Meeting of the
                                                          American Society of
                                                          Hematology; December
                                                          9-12, 2017; Atlanta,
                                                          GA.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-27"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Kruse-Jarres R,
                                                              Callaghan MU,
                                                              Croteau SE, et al.
                                                              Surgical
                                                              experience in two
                                                              multicenter,
                                                              open-label phase 3
                                                              studies of
                                                              emicizumab in
                                                              persons with
                                                              hemophilia A with
                                                              inhibitors (HAVEN
                                                              1 and HAVEN 2)
                                                              [abstract].
                                                              Presented at: 59th
                                                              Annual Meeting of
                                                              the American
                                                              Society of
                                                              Hematology;
                                                              December 9-12,
                                                              2017; Atlanta, GA.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="200761c8-5574-419d-b19d-9dae9a01dc88"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="28"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Mahlangu J, Oldenburg
                                                          J, Paz-Priel I, et al.
                                                          Emicizumab prophylaxis
                                                          in patients who have
                                                          hemophilia A without
                                                          inhibitors.
                                                          <i>N Engl J Med</i>.
                                                          2018;379(9):811-822.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-28"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Mahlangu J,
                                                              Oldenburg J,
                                                              Paz-Priel I, et
                                                              al. Emicizumab
                                                              prophylaxis in
                                                              patients who have
                                                              hemophilia A
                                                              without
                                                              inhibitors.
                                                              <i>N Engl J Med</i
                                                              >.
                                                              2018;379(9):811-822.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="82f0bbf1-d15d-46be-84a2-9cb85dd9f9a3"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="29"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          HEMLIBRA Summary of
                                                          Product
                                                          Characteristics. Roche
                                                          Registration Limited;
                                                          2019.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-29"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              HEMLIBRA Summary
                                                              of Product
                                                              Characteristics.
                                                              Roche Registration
                                                              Limited; 2019.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="2ee3c6a7-ed42-4d51-8495-be3f339a6c8b"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="30"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Santagostino E,
                                                          Oldenburg J, Chang T,
                                                          et al. Surgical
                                                          experience from four
                                                          phase III studies
                                                          (HAVEN 1–4) of
                                                          emicizumab in persons
                                                          with haemophilia A
                                                          (PwHA) with or without
                                                          FVIII inhibitors.
                                                          Slide deck presented
                                                          at: International
                                                          Society on Thrombosis
                                                          and Haemostasis 2019
                                                          Congress; July 6–10,
                                                          2019; Melbourne,
                                                          Australia.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-30"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Santagostino E,
                                                              Oldenburg J, Chang
                                                              T, et al. Surgical
                                                              experience from
                                                              four phase III
                                                              studies (HAVEN
                                                              1–4) of emicizumab
                                                              in persons with
                                                              haemophilia A
                                                              (PwHA) with or
                                                              without FVIII
                                                              inhibitors. Slide
                                                              deck presented at:
                                                              International
                                                              Society on
                                                              Thrombosis and
                                                              Haemostasis 2019
                                                              Congress; July
                                                              6–10, 2019;
                                                              Melbourne,
                                                              Australia.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="225d9d85-70a6-49ef-ae0f-efa2c5e93e3c"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="31"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Sampei Z, Igawa T,
                                                          Soeda T, et al.
                                                          Identification and
                                                          multidimensional
                                                          optimization of an
                                                          asymmetric bispecific
                                                          IgG antibody mimicking
                                                          the function of factor
                                                          VIII cofactor
                                                          activity.
                                                          <i>PLoS One</i>.
                                                          2013;8(2):e57479.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-31"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Sampei Z, Igawa T,
                                                              Soeda T, et al.
                                                              Identification and
                                                              multidimensional
                                                              optimization of an
                                                              asymmetric
                                                              bispecific IgG
                                                              antibody mimicking
                                                              the function of
                                                              factor VIII
                                                              cofactor activity.
                                                              <i>PLoS One</i>.
                                                              2013;8(2):e57479.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>

                                                    <li
                                                      id="bb0a4f62-3505-4833-a5a3-eef2cf89a1e9"
                                                      class="
                                                        cmp-references__item
                                                      "
                                                      data-reference-number="32"
                                                    >
                                                      <div
                                                        class="
                                                          cmp-references__item-content
                                                        "
                                                      >
                                                        <p>
                                                          Santagostino E, Parnes
                                                          A, Dhalluin C, et al.
                                                          Surgical procedures in
                                                          persons with
                                                          haemophilia A (PwHA)
                                                          without inhibitors
                                                          receiving emicizumab –
                                                          experience from the
                                                          HAVEN 3 study.
                                                          Presented at: 12th
                                                          Annual Congress of the
                                                          European Association
                                                          of Haemophilia and
                                                          Allied Disorders
                                                          (EAHAD); February 6–8,
                                                          2019; Prague, Czech
                                                          Republic.
                                                        </p>
                                                      </div>

                                                      <div class="cmp-tooltip">
                                                        <div
                                                          class="
                                                            cmp-tooltip__content-wrapper
                                                          "
                                                          id="reference-32"
                                                        >
                                                          <span
                                                            class="
                                                              cmp-tooltip__close
                                                            "
                                                            aria-role="button"
                                                            ><i
                                                              class="
                                                                fa fa-times
                                                              "
                                                              title="Close"
                                                              aria-hidden="true"
                                                            ></i
                                                          ></span>
                                                          <div
                                                            class="
                                                              cmp-tooltip__content
                                                            "
                                                          >
                                                            <p>
                                                              Santagostino E,
                                                              Parnes A, Dhalluin
                                                              C, et al. Surgical
                                                              procedures in
                                                              persons with
                                                              haemophilia A
                                                              (PwHA) without
                                                              inhibitors
                                                              receiving
                                                              emicizumab –
                                                              experience from
                                                              the HAVEN 3 study.
                                                              Presented at: 12th
                                                              Annual Congress of
                                                              the European
                                                              Association of
                                                              Haemophilia and
                                                              Allied Disorders
                                                              (EAHAD); February
                                                              6–8, 2019; Prague,
                                                              Czech Republic.
                                                            </p>
                                                          </div>
                                                        </div>
                                                      </div>
                                                    </li>
                                                  </ul>
                                                </li>

                                                <li
                                                  class="
                                                    cmp-references__list-column
                                                    cmp-references__list-column--2
                                                  "
                                                >
                                                  <ul></ul>
                                                </li>
                                              </ul>
                                            </div>
                                          </div>
                                        </div>
                                      </div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                      <div class="footer"></div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>

    <!-- Tooltip template -->
    <div class="hidden">
      <div class="cmp-tooltip">
        <div class="cmp-tooltip__content-wrapper" id="tooltip-template">
          <span class="cmp-tooltip__close" aria-role="button"
            ><i class="fa fa-times" title="Close" aria-hidden="true"></i
          ></span>
          <div class="cmp-tooltip__content">
            <div class="cmp-tooltip__header"></div>
            <div class="cmp-tooltip__body"></div>
          </div>
        </div>
      </div>
    </div>

    <script
      type="text/javascript"
      src="../etc.clientlibs/gene-common/clientlibs/clientlib-analytics.min.js"
    ></script>

    <script>
      /**
       * INITIALIZE THE DIGITAL DATA LAYER API
       * -- Generate the initial page digital data object
       */
      (function setUpDTMAnalytics(win, ddlAPI) {
        if (ddlAPI) {
          ddlAPI.init();
        }
      })(window, GENE.DigitalDataAPI);
    </script>

    <div class="third-part-modal exit-modal">
      <div class="xfpage page basicpage">
        <div class="xf-content-height">
          <div class="aem-Grid aem-Grid--12 aem-Grid--default--12">
            <div
              class="
                container
                responsivegrid
                aem-GridColumn aem-GridColumn--default--12
              "
            >
              <div class="cmp-container component-row">
                <div class="cmp-container__inner content-container">
                  <div class="modal">
                    <div
                      class="cmp-modal cmp-modal--basic modal-third-party"
                      data-days-until-next-trigger="1"
                      data-modal-id="third-party"
                      role="dialog"
                    >
                      <div class="cmp-modal__box cmp-modal__box--large">
                        <header class="cmp-modal__header">
                          <div role="heading" class="cmp-modal__heading">
                            <p>Link to Third-Party Site</p>
                          </div>
                          <a
                            role="button"
                            class="
                              cmp-modal__close cmp-modal__close-icon
                              no-external-icon
                            "
                            href="#"
                            target="_self"
                            data-analytics='{\"component\":\"\",\"destinationTitle\":\"Close\",\"location\":\"\",\"destinationURL\":\"#\",\"type\":\"state\"}'
                          >
                            <i class="fa fa-times" aria-hidden="true"></i>
                            <span class="sr-only" hidden="">Close</span>
                          </a>
                        </header>

                        <div class="cmp-modal__body">
                          <div class="text section">
                            <div
                              class="cmp-text"
                              data-analytics-component="text"
                              data-table-stacked-on-mobile="false"
                              data-table-lock-first-column="false"
                            >
                              <p>
                                The link you have selected will take you away
                                from this site to one that is not owned or
                                controlled by Genentech, Inc. Genentech, Inc.
                                makes no representation as to the accuracy of
                                the information contained on sites we do not own
                                or control. Genentech does not recommend and
                                does not endorse the content on any third-party
                                websites. Your use of third-party websites is at
                                your own risk and subject to the terms and
                                conditions of use for such sites.
                              </p>
                            </div>
                          </div>
                        </div>
                      </div>
                      <div class="cmp-modal__backdrop cmp-modal__close"></div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <script>
      window.allowedExternalUrls = [
        'https://www.hemlibra.com/',
        'https://hemlibracopay.com/',
      ];
    </script>

    <div id="glossary-list" data-glossary-json="[]"></div>

    <script
      type="text/javascript"
      src="../etc.clientlibs/genentech-core/clientlibs/clientlib-dependencies.min.js"
    ></script>
    <script
      type="text/javascript"
      src="../etc.clientlibs/genentech-core/clientlibs/clientlib-base.min.js"
    ></script>
    <script
      type="text/javascript"
      src="/etc.clientlibs/hemlibra-hcp/clientlibs/clientlib-dependencies.min.js"
    ></script>
    <script
      type="text/javascript"
      src="../etc.clientlibs/genentech-core/components/structure/loadingoverlay/v1/loadingoverlay/clientlibs/js.min.js"
    ></script>
    <script
      type="text/javascript"
      src="../etc.clientlibs/hemlibra-hcp/clientlibs/clientlib-base.min.js"
    ></script>
    <script
      type="text/javascript"
      src="/etc.clientlibs/hemlibra-hcp/clientlibs/clientlib-site.min.js"
    ></script>

    <script
      src="../recaptcha/api.js?onload=recaptchaReady"
      async=""
      defer=""
    ></script>
  </body>
</html>
